Skip to main content
MedVellum
MCQsExamsAtlas
DashboardPricing
MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳Obstetrics & Gynaecology✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳Obstetrics & Gynaecology✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳

MedVellum.

The folio

Exam-exhaustive medical education across every specialty — evidence-graded topics, engraved plates, and practice in every written and oral format. Educational content only — not medical advice.

llms.txt · psychiatry LLM catalog · sitemap · privacy · terms

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship
  • Paediatrics Fellowship
  • Physician Medicine
  • Obstetrics & Gynaecology

Study & account

  • MCQ practice
  • Topic library
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Folio edition · Set in Instrument Serif & Archivo

Phys · Topics

Topics

237 units across 15 domains — Consultant-physician-depth topic guides across all DWE blueprint domains.

Back to PhysJump to first domain
Physician Medicine Topics
Plate — physMedVellum Press
237Units
15Domains
general-medicinerenalhaematologicalhepaticgastrointestinalendocrinecardiovascularpharmacologicalrheumatologicalinfectiousrespiratoryoncologicalgeriatricdermatologicalneurological
AtlasPhysTopics

Domain

general-medicine

43

high

Abdominal Examination Routine — The DCE Short-Case Systematic Approach

Consultant-physician-depth guide to the systematic abdominal examination for the DCE short case and MRCP PACES. Covers the reproducible head-to-toe twelve-step routine, the key physical signs and their interpretation (clubbing, palmar erythema, Dupuytren contracture, spider naevi, scleral icterus, Kayser-Fleischer rings, Virchow node, caput medusae), the differentiation of organomegaly (liver versus spleen versus kidney by direction, percussion, ballotability and surface), the evidence-based examination of ascites (shifting dullness, fluid thrill), the abdominal aortic aneurysm (expansile pulsation), the signs of peritonitis, the standard oral presentation template, and the discussion questions the examiner will ask. Structured for FRACP DCE and MRCP PACES. Every sign is referenced to the JAMA Rational Clinical Examination series.

Open

high

Anaphylaxis

Consultant-physician-depth guide to anaphylaxis — the NIAID/FAAN diagnostic criteria applied at the bedside, IgE-mediated and non-IgE mechanisms, the adrenaline-first acute algorithm with refractory management and the beta-blocker trap, biphasic reactions and observation, serum tryptase timing and interpretation, triggers and cofactors including ACE inhibitors and beta-blockers, perioperative anaphylaxis, venom immunotherapy and drug desensitisation, and the discharge bundle — structured for FRACP DWE and DCE preparation.

Open

high

Cardiovascular System Examination — The Classic DCE Short-Case Routine

Consultant-physician-depth guide to the systematic cardiovascular system examination as performed in the FRACP, MRCP PACES and ABIM clinical examinations. Covers the reproducible eleven-step routine from the end-of-bed survey through the hands, face, eyes, neck and jugular venous pressure, the praecordium (inspection, palpation of the apex beat and thrills), the systematic four-area auscultation with the diaphragm and bell, the dynamic manoeuvres (respiration, Valsalva, squat-to-stand, hand grip), the back, abdomen and legs, the timing-based murmur framework, the candidate's spoken presentation template, the examiner discussion by finding, and the common examination traps and pitfalls.

Open

medium

Clinical Research AND Research Ethics

Consultant-physician depth guide to Clinical Research AND Research Ethics for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

medium

Confidentiality Privacy AND Mandatory Reporting

Consultant-physician depth guide to Confidentiality Privacy AND Mandatory Reporting for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

high

Cultural Competence and Indigenous Health (ANZ Context)

Consultant-physician-depth guide to cultural safety, cultural competence and the health of Aboriginal and Torres Strait Islander peoples (Australia) and Maori (New Zealand) for FRACP DWE and DCE — the cultural safety framework (cultural awareness vs cultural competence vs cultural safety, with safety defined by the patient), the social determinants of health and the legacy of colonisation, the life-expectancy gap and the burden of disease (rheumatic heart disease, chronic kidney disease, type 2 diabetes, cardiovascular disease, mental health, chronic otitis media, scabies and skin sores), the ARF and RHD prevention pathway (primary prevention with Strep A management, secondary prevention with benzathine penicillin G IM every 3 to 4 weeks per RHD Australia 2020 guideline), the Maori health frameworks (Te Whare Tapa Wha, the Treaty of Waitangi principles of partnership participation and protection, Whanau Ora), the National Agreement on Closing the Gap, the RACP curriculum requirements, and the practical clinical approaches to culturally safe care — involving Aboriginal Health Workers, using professional interpreters, respecting Sorry Business, understanding kinship, building trust, and reflecting on one's own cultural identity and power.

Open

high

Drug Allergy and Desensitisation

Consultant-physician-depth guide to drug allergy and desensitisation for FRACP DWE and DCE — the allergy-versus-intolerance distinction, the immediate IgE-mediated versus delayed T-cell mediated classification, beta-lactam allergy with penicillin skin testing and side-chain-based cross-reactivity and the modern delabeling strategy, non-beta-lactam allergies (sulfonamide, NSAID hypersensitivity and aspirin-exacerbated respiratory disease, local anaesthetics, radiocontrast media), the severe cutaneous adverse reactions DRESS and Stevens-Johnson syndrome or toxic epidermal necrolysis with the RegiSCAR and SCORTEN scores, and the principle and indications of drug desensitisation with the Brigham 12-step protocol and drug provocation testing as the diagnostic gold standard.

Open

high

END OF Life Decision Making

Consultant-physician depth guide to END OF Life Decision Making for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

high

Evidence-Based Medicine and Critical Appraisal

Consultant-physician-depth guide to evidence-based medicine and critical appraisal for FRACP DWE and DCE — the Sackett definition of EBM (integration of best research evidence, clinical expertise and patient values), the hierarchy of evidence (case reports through to systematic reviews and meta-analyses), the study designs (cross-sectional for prevalence, case-control for rare diseases reporting odds ratios and prone to recall bias, cohort for common diseases reporting relative risk and establishing temporality, RCT as the gold standard for therapy with randomisation, allocation concealment, blinding and intention-to-treat analysis), the critical-appraisal frameworks (CASP checklists, CONSORT for RCTs, STROBE for observational studies, PRISMA for systematic reviews, QUADAS-2 for diagnostic accuracy), the PICO framework, effect sizes (relative risk, odds ratio, absolute risk reduction, NNT, NNH), confidence intervals (95 per cent CI, crossing 1 for a ratio means non-significant), p-values and the distinction between statistical and clinical significance, Type I and Type II errors and power, intention-to-treat versus per-protocol analysis, subgroup analyses and the hazard of multiple comparisons, the bias types (selection, information or recall, publication detected by funnel plot, confounding, lead-time, length-time, spectrum), internal versus external validity, forest plots and meta-analysis with I-squared heterogeneity and fixed versus random effects, applying evidence to the individual patient, and the GRADE system for guideline development (high, moderate, low, very low quality; strong versus weak recommendations).

Open

high

Examination OF THE Unconscious Patient

Consultant-physician depth guide to Examination OF THE Unconscious Patient for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

high

Lymph Node Examination and Organomegaly — The DCE Short-Case Systematic Approach

Consultant-physician-depth guide to the systematic examination of lymph nodes and organomegaly (splenomegaly and hepatomegaly) for the DCE short case and MRCP PACES. Covers the reproducible head-to-toe lymph node routine (head and neck, axillary, epitrochlear, inguinal, popliteal), the five characteristics of every palpable node (size, consistency, mobility, tenderness, overlying skin), the interpretation of node consistency (soft reactive, firm lymphoma, rubbery Hodgkin, hard metastatic, matted TB or lymphoma), the significance of the Virchow node, the correct technique for splenomegaly (start in the right iliac fossa, move diagonally toward the left costal margin along the tenth rib, left hand behind the ribs to lift the spleen forward), the differentiation of spleen from kidney (cannot get above, dull to percussion, notch, moves with respiration), the grading of splenomegaly and the causes of massive splenomegaly (CML, myelofibrosis, chronic malaria, visceral leishmaniasis, Gaucher disease), the examination and description of hepatomegaly, the standard oral presentation template, and the discussion questions the examiner will ask. Structured for FRACP DCE and MRCP PACES. Every sign is referenced to the JAMA Rational Clinical Examination series and the foundational lymphadenopathy reviews.

Open

high

Medical Errors and Open Disclosure

Consultant-physician guide to medical errors and open disclosure: the four definitions that anchor the field (medical error, adverse event, near miss, never event), the Swiss cheese model of Reason (active failures and latent conditions, slips lapses and mistakes, errors of execution versus planning), the types of error by stage of care (diagnostic, treatment, preventive, other), the high-alert medicines that concentrate risk (insulin, anticoagulants, opioids), the Australian Open Disclosure Framework (the staged process and the four elements — apology, factual explanation, acknowledgement, prevention), the duty of candour, root cause analysis and the London Protocol, the just culture algorithm, and the reporting and medico-legal pathways (incident report, AHPRA mandatory notification, coronial referral, medical defence organisation).

Open

high

Medical Ethics Autonomy Beneficence NON Maleficence Justice

Consultant-physician depth guide to Medical Ethics Autonomy Beneficence NON Maleficence Justice for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

high

Medical Ethics, Capacity and Consent

Consultant-physician-depth guide to medical ethics, capacity and consent for FRACP DWE and DCE — the four principles of biomedical ethics (Beauchamp and Childress: autonomy, beneficence, non-maleficence, justice), the functional two-stage test of capacity (understanding, retaining, using and weighing, communicating — Appelbaum 2007), the presumption of capacity and its decision-specific and time-specific nature, valid consent (informed, voluntary, capacitous), treatment without consent (emergency doctrine of necessity, mental health legislation, court order), advance care planning (binding advance refusals, values statements, ceilings of treatment, not-for-resuscitation orders that do not abandon), confidentiality and its limits (mandatory reporting, imminent risk, court order), and professional regulation (AHPRA, GMC, revalidation) — with the SPIKES protocol, the Mental Capacity Act 2005 five principles, and the ANZ guardianship and substitute decision-maker framework.

Open

high

Multi-morbidity and Complex Care — Managing the Patient with Multiple Chronic Diseases

Consultant-physician-depth guide to multi-morbidity (two or more chronic conditions): epidemiology (Barnett 2012), the failure of the single-disease paradigm (Boyd 2005), the comprehensive assessment (CGA, medication reconciliation and review with STOPP/START and Beers, function, cognition, frailty, social), the five management principles (patient-centred, holistic, prioritised, coordinated, evidence-informed), the key multi-morbidity scenarios (HF with CKD, diabetes with CVD, AF with CKD and falls, COPD with HF), deprescribing, advance care planning, and care coordination. Structured for FRACP DWE and DCE preparation.

Open

high

Neurological Examination — Cranial Nerves

Classic DCE short-case routine for cranial nerve examination (CN I to XII): the systematic sequence, the signs to elicit, their localising value, a say-aloud presentation template, examiner discussion questions and the pitfalls that fail candidates — for FRACP DCE, MRCP PACES and ABIM preparation.

Open

high

Neurological Examination — Speech and Higher Mental Function

Classic DCE short-case routine for speech and higher mental function: the systematic six-step speech sequence, the aphasia classification (fluency, comprehension, repetition), dysarthria and dysphonia, the cognitive domains and their bedside tests (orientation, attention, memory, language, visuospatial, executive), the MMSE, MoCA and ACE-III, a say-aloud presentation template, examiner discussion and the pitfalls that fail candidates — for FRACP DCE, MRCP PACES and ABIM preparation.

Open

high

Neurological Examination of the Lower Limbs — The DCE Short-Case Routine

Consultant-physician-depth guide to the systematic neurological examination of the lower limbs for the FRACP DCE short case and the MRCP PACES neurological station. Covers the eight-step routine — inspection including gait and stance, tone with ankle clonus, power by myotome, reflexes by root level, the plantar response, coordination with the heel-shin test, the spinothalamic and dorsal column sensory pathways, and the gait assessment — the interpretation of each sign, the UMN versus LMN framework, the presentation template the candidate delivers aloud, and the examiner discussion questions by finding. Addresses gait patterns (hemiplegic, parkinsonian, ataxic, high-stepping, waddling), the Romberg test, muscle wasting patterns, foot deformity (pes cavus in Friedreich ataxia and Charcot-Marie-Tooth), tone abnormalities (spasticity with clonus, lead-pipe rigidity), the MRC power grading with myotomes from L2 to S2, reflex levels (knee jerk L3/4, ankle jerk S1/2), the absent ankle jerk with preserved knee jerk of diabetic neuropathy and the delayed relaxation of hypothyroidism, the Babinski sign, the heel-shin test for cerebellar function, stocking-distribution sensory loss, and the common examination traps. Structured for FRACP DCE and MRCP PACES preparation.

Open

high

Neurological Examination of the Upper Limbs — The DCE Short-Case Routine

Consultant-physician-depth guide to the systematic neurological examination of the upper limbs for the FRACP DCE short case and the MRCP PACES neurological station. Covers the eight-step routine — inspection, tone, power by myotome, reflexes, coordination, sensory, cortical sensory, and functional testing — the interpretation of each sign, the UMN versus LMN framework, the presentation template the candidate delivers aloud, and the examiner discussion questions by finding. Addresses muscle wasting patterns (dorsal interossei in MND, thenar eminence in median nerve, hypothenar in ulnar nerve), tremor classification, tone abnormalities (spastic, lead-pipe, cogwheel, hypotonic), the MRC power grading, reflex levels and the inverted supinator sign, the finger-nose test and dysdiadochokinesia, the spinothalamic and dorsal column sensory pathways, stereognosis and graphesthesia, and the common examination traps. Structured for FRACP DCE and MRCP PACES preparation.

Open

high

Perioperative Medicine — Physician Assessment and Optimisation Before Surgery

Consultant-physician-depth guide to perioperative medicine: preoperative cardiac risk stratification (Revised Cardiac Risk Index, MET capacity, stress testing), pulmonary optimisation, perioperative diabetes management (metformin, SGLT2 inhibitors, insulin, variable-rate IV insulin infusion), anticoagulation management and reversal (warfarin bridging, DOACs, PCC, idarucizumab, andexanet alfa), chronic medication management, VTE prophylaxis (Caprini, Padua), postoperative complications, and Enhanced Recovery After Surgery (ERAS). Structured for FRACP DWE and DCE preparation.

Open

medium

Physician Wellbeing Burnout AND Professional Resilience

Consultant-physician depth guide to Physician Wellbeing Burnout AND Professional Resilience for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

high

Preoperative Medical Assessment AND Optimisation

Consultant-physician depth guide to Preoperative Medical Assessment AND Optimisation for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

high

Primary Immunodeficiency in Adults

Consultant-physician guide to when to suspect primary immunodeficiency in adults (Jeffrey Modell Foundation warning signs), the four-arm classification (humoral, cellular, complement, phagocyte), the adult-presentation disorders in each arm (CVID as the most common symptomatic PID in adults; selective IgA deficiency; specific antibody deficiency; terminal complement and properdin deficiency with recurrent Neisseria; hereditary angioedema from C1 inhibitor deficiency; chronic granulomatous disease), and the structured investigation pathway (immunoglobulins, vaccine response, lymphocyte subsets, CH50 and AH50, and the mandatory HIV test to exclude secondary causes). Treatment principles for immunoglobulin replacement therapy, complement-deficiency prevention, and HAE-specific acute and prophylactic therapy are covered at consultant viva depth.

Open

medium

Quality AND Safety IN Medicine

Consultant-physician depth guide to Quality AND Safety IN Medicine for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

high

Rapid Response Systems and MET Calls — The System That Catches the Deteriorating Patient

Consultant-physician-depth guide to the Rapid Response System as a patient-safety structure, not a resuscitation technique. Covers the four limbs of the RRS (afferent detection, efferent response, governance, quality improvement), track-and-trigger systems (NEWS2, Between the Flags, COMPASS), single-parameter MET calling criteria, the MET versus RRT versus critical care outreach models, the three failure-to-rescue modes (recognise, communicate, respond), SBAR escalation, the clinical response to a MET call, the post-MET plan and ceiling of care, governance and audit, and the evidence base (MERIT, Chan, Maharaj). Structured for FRACP DWE and DCE preparation, with ANZ primary anchoring.

Open

high

Respiratory System Examination — DCE Short-Case Routine

Consultant-physician guide to the systematic respiratory system examination for the DCE short case: the eleven-step routine (end of bed, hands, face, neck, anterior chest, posterior chest, legs, additional tests), the key physical signs and their physiological basis, the differential diagnosis from individual signs, the model presentation template, the examiner discussion questions, and the classic exam traps — the routine that every FRACP, MRCP PACES, and ABIM candidate must perform flawlessly.

Open

high

Rheumatological Examination of the Hands — The DCE Short-Case Routine

Consultant-physician-depth guide to the systematic rheumatological examination of the hands for the FRACP DCE short case and the MRCP PACES Station 3 — the single most frequently set short case in the examination. Covers the six-step routine (inspection, palpation, range of motion, function, additional sites, neurovascular), the discriminating deformities of RA (ulnar deviation, swan-neck, boutonniere, Z-deformity thumb), OA (Heberden and Bouchard nodes, first CMC squaring), PsA (dactylitis, nail pitting, onycholysis), gout (tophi), SLE (Jaccoud arthropathy), SSc (sclerodactyly) and dermatomyositis (Gottron papules), the synovitis versus bony swelling distinction, the DAS28 joint count, the carpal tunnel bedside tests, the say-aloud presentation templates, and the examiner discussion questions by finding.

Open

high

Rheumatological Examination Spine AND Lower Limbs

Consultant-physician depth guide to Rheumatological Examination Spine AND Lower Limbs for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

high

Skin Examination for Systemic Disease — DCE Short-Case Routine

Consultant-physician guide to the systematic skin examination for the DCE short case: the six-step routine from general inspection through hands, face, trunk, legs and specific patterns, the morphology vocabulary (macule through purpura), the distribution and arrangement clues (photosensitive, acral, dermatomal, annular, livedoid), and the high-yield skin-to-system sign map — malar rash of SLE sparing nasolabial folds, heliotrope and Gottron papules of dermatomyositis, palmar erythema and spider naevi of cirrhosis, acanthosis nigricans of insulin resistance and GI malignancy, erythema nodosum and pyoderma gangrenosum, necrobiosis lipoidica, pretibial myxoedema, dermatitis herpetiformis of coeliac disease, and the purpura and livedo patterns of vasculitis and antiphospholipid syndrome — with the model presentation template, the examiner discussion questions, and the classic exam traps.

Open

high

The Deteriorating Ward Patient — Recognition, Systematic Assessment and Escalation

Consultant-physician-depth guide to recognising and managing the acutely deteriorating ward patient. Covers the hours of warning before arrest, NEWS2 and track-and-trigger systems, the ABCDE structured assessment, the common causes of ward deterioration (sepsis, hypovolaemia, cardiac, respiratory, neurological, drug-related, metabolic), MET call criteria and escalation thresholds, SBAR structured handover, rapid response system evidence, and end-of-life decision-making including ceilings of care. Structured for FRACP DWE and DCE preparation.

Open

high

The Undifferentiated Altered Mental Status — A Systematic Diagnostic Approach

Consultant-physician-depth guide to the systematic approach to the acutely confused or delirious patient. Covers the ABCDE resuscitation-first principle, the DIMTOP mnemonic for causes (Drugs, Infection, Metabolic, Trauma, Oxygen, Psychiatric), the collateral history, the focused neurological and systemic examination, the tiered investigation ladder (bedside glucose, blood gas, electrolytes, infection screen, CT head, lumbar puncture, EEG), the rapidly reversible causes (glucose, oxygen, sodium, calcium, thiamine), the Confusion Assessment Method (CAM) diagnostic algorithm, the management principle of treating the underlying cause with symptomatic sedation as a last resort, and the special considerations for the elderly, the postoperative, and the immunocompromised patient. Structured for FRACP DWE and DCE preparation.

Open

high

Thyroid Status and Neck Examination — DCE Short-Case Routine

Consultant-physician guide to the systematic thyroid status examination for the DCE short case: the nine-step routine performed from behind the patient (general inspection, hands, pulse, eyes, neck inspection, neck palpation, percussion, auscultation, reflexes and legs), the hyperthyroid and hypothyroid clinical phenotypes, the Graves-specific eye and skin signs (exophthalmos, lid lag, lid retraction, ophthalmoplegia, thyroid acropachy, pretibial myxoedema), the NOSPECS and CAS scoring systems, the model presentation template, the examiner discussion questions, and the classic exam traps — the routine every FRACP, MRCP PACES, and ABIM candidate must perform flawlessly.

Open

high

Undifferentiated Back Pain — A Systematic Diagnostic Approach

Consultant-physician-depth guide to the systematic approach to back pain in the physician setting. Covers the triage framework (non-specific mechanical, radicular, or red-flag serious pathology); the complete differential — mechanical (musculoskeletal, disc herniation, facet joint, spinal stenosis), inflammatory (axial spondyloarthritis — ankylosing spondylitis, psoriatic and enteropathic spondylitis), infective (vertebral osteomyelitis, epidural abscess, discitis), malignant (bone metastases — breast, lung, prostate, kidney, thyroid; myeloma; primary bone tumour), metabolic (osteoporotic vertebral fracture) and referred (pancreatic cancer, AAA, renal, pelvic); the NICE NG59 red flags and cauda equina syndrome; the focused history and the systematic spine and lower-limb neurological examination (straight leg raise, femoral stretch test, per rectal); the targeted investigations (most mechanical pain needs no imaging; FBC, CRP, ESR, PSA, calcium, ALP, electrophoresis, Bence-Jones when red flags; X-ray, MRI, CT); and the management of mechanical back pain (analgesia, stay active, physiotherapy, CBT, multidisciplinary pain programme). Structured for FRACP DWE and DCE preparation.

Open

high

Undifferentiated Chest Pain — A Systematic Diagnostic Approach

Consultant-physician-depth guide to the diagnostic approach to the patient with chest pain of unknown cause. Covers the deadly six causes (acute coronary syndrome, pulmonary embolism, aortic dissection, tension pneumothorax, cardiac tamponade, oesophageal rupture), the OPQRST history framework, pain-character-based differential diagnosis (central crushing, pleuritic, tearing interscapular, burning epigastric, positional), the focused cardiovascular and respiratory examination, the mandatory ECG and its subtleties (STEMI equivalents including Wellens, hyperacute T waves, new LBBB, Sgarbossa criteria), the high-sensitivity troponin 0/1h and 0/3h algorithms, the chest X-ray discriminators, the Wells score and D-dimer pathway for pulmonary embolism, the HEART score for early risk stratification, the Modified Early Warning Score, the approach to atypical presentations (women, elderly, diabetic), and the DCE long-case and short-case approach. Structured for FRACP DWE and DCE preparation.

Open

high

Undifferentiated Dyspnoea — A Systematic Diagnostic Approach

Consultant-physician-depth guide to the diagnostic approach to the patient with breathlessness of unknown cause. Covers the acute-to-chronic time-course framework and its differentials, the focused history and examination discriminators, the first-tier investigations (blood gas, chest X-ray, ECG, NT-proBNP, troponin, D-dimer, FBC, U&E) and second-tier investigations (echo, PFTs, CTPA, V/Q, HRCT, cardiopulmonary exercise testing), the clinical decision rules (two-level Wells score for PE, CURB-65 for pneumonia, Light's criteria for pleural effusion), the BLUE protocol for bedside lung ultrasound, the natriuretic peptide algorithm for cardiac versus respiratory dyspnoea, and the DCE long-case and short-case approach. Structured for FRACP DWE and DCE preparation.

Open

high

Undifferentiated Fatigue — A Systematic Diagnostic Approach

Consultant-physician-depth guide to the diagnostic approach to the patient with chronic fatigue. Covers the three functional categories (physiological — sleep deprivation, overwork, deconditioning, pregnancy, post-viral; psychological — depression, anxiety, chronic stress, burnout, grief; physical or systemic — anaemia, thyroid disease, diabetes, cardiac failure, sleep apnoea, CKD, hepatic failure, COPD, malignancy, autoimmune disease, chronic infection, drug-related, nutritional, Addison disease, narcolepsy, myasthenia gravis), the focused history with the PHQ-2 and GAD-2 mood screens, the systematic examination with the bedside discriminators (pallor, koilonychia, clubbing, hyperpigmentation, the postural blood pressure, the thyroid), the two-tier investigation framework (Tier 1 — FBC, ferritin, B12, folate, U and E, LFTs, TFTs, CRP, glucose and HbA1c, vitamin D, urinalysis, CXR, ECG, pregnancy test; Tier 2 — autoimmune screen, HIV and hepatitis serology, troponin and BNP, sleep study, short Synacthen), the principle of avoiding over-investigation, the management of the cause and of the unexplained fatigue (reassurance, sleep hygiene, graded activity, CBT, medication review, depression treatment, planned review), and the specific guidance on ME and CFS (NICE 2021 NG206 — the withdrawal of graded exercise therapy, the pacing and energy management) and post-COVID condition (long COVID). Structured for FRACP DWE and DCE, MRCP and ABIM.

Open

high

Undifferentiated Fever and Fever of Unknown Origin — Definition, Differential and Staged Diagnostic Approach

Consultant-physician-depth guide to undifferentiated fever and fever of unknown origin (FUO). Covers the classic Petersdorf and Beeson definition and the modern Durack and Street revision with the four subclasses (classic, nosocomial, neutropenic, HIV-associated); the four diagnostic buckets (infection, malignancy, non-infectious inflammatory disease, miscellaneous) and the high-yield members of each; the focused history (travel, animal exposure, occupation, drugs, immunosuppression); the examination targets including fundoscopy, lymph nodes, murmurs, skin and temporal arteries; the staged investigation protocol from Tier 1 (FBC, CRP, ESR, blood cultures, urinalysis, CXR, HIV) through Tier 2 (autoimmune screen, IGRA, viral serology, echocardiogram, CT chest abdomen pelvis, LDH, beta-2 microglobulin) to Tier 3 (FDG-PET-CT, bone marrow biopsy, temporal artery biopsy, liver biopsy); the principle that empiric antibiotic and steroid therapeutic trials obscure diagnosis and are reserved for the deteriorating patient; factitious and fraudulent fever; and the favourable prognosis of the stable undiagnosed FUO. Structured for FRACP DWE and DCE preparation.

Open

high

Undifferentiated Lymphadenopathy — A Systematic Diagnostic Approach

Consultant-physician-depth guide to the diagnostic approach to the patient with lymph node enlargement of unknown cause. Covers the localised-versus-generalised framework and its regional differentials (cervical, supraclavicular Virchow, axillary, inguinal, epitrochlear), the generalised causes (infection — EBV infectious mononucleosis, CMV, HIV, TB, toxoplasmosis, syphilis; haematological — Hodgkin and non-Hodgkin lymphoma, CLL, ALL; autoimmune — SLE, RA, sarcoid; drug — phenytoin pseudolymphoma; metastatic malignancy), the focused history and examination discriminators (node size, consistency, mobility, tenderness, matting; the B symptoms of lymphoma; the exposure history), the red-flag features that mandate biopsy (supraclavicular node, hard fixed node, node above 2 cm, persistence beyond 6 weeks, B symptoms, hepatosplenomegaly), the first-tier investigations (FBC, film, LDH, EBV serology, HIV, toxoplasma, syphilis, chest X-ray, ultrasound), the biopsy decision (excisional biopsy as the gold standard for lymphoma, FNA for metastatic or infective, core biopsy when excision is not feasible), the Lugano classification and the revised International Prognostic Index, and lymphadenopathy in the immunocompromised host. Structured for FRACP DWE and DCE preparation.

Open

high

Undifferentiated Oedema — A Systematic Diagnostic Approach

Consultant-physician-depth guide to the diagnostic approach to the patient with oedema of unknown cause. Covers the Starling forces framework (capillary hydrostatic pressure, plasma oncotic pressure, capillary permeability, lymphatic drainage) and its revised glycocalyx model, the localised-versus-generalised classification (unilateral leg — DVT, cellulitis, chronic venous insufficiency, compartment syndrome, lymphoedema; bilateral legs — systemic causes), the systemic causes (cardiac — heart failure, cor pulmonale, constrictive pericarditis; hepatic — cirrhosis, ascites, the serum-ascites albumin gradient; renal — nephrotic, nephritic, CKD, AKI; drugs — calcium channel blockers, NSAIDs, steroids, pioglitazone, minoxidil; endocrine — myxoedema, pretibial myxoedema; nutritional — protein malnutrition, refeeding; idiopathic — cyclical oedema), the focused history and examination discriminators (distribution, pitting, the JVP, the Stemmer sign, the skin), the first-tier investigations (urinalysis, FBC, U&E, LFTs, albumin, TFTs, NT-proBNP) and second-tier investigations (echocardiogram, 24-hour urine protein, renal biopsy, diagnostic ascitic tap with SAAG), and the cause-specific management. Structured for FRACP DWE and DCE, MRCP and ABIM.

Open

high

Undifferentiated Palpitations — Diagnostic Challenge

Consultant-physician guide to the patient presenting with undifferentiated palpitations — the awareness of heartbeat — at FRACP DWE and DCE depth: the four-descriptor classification (regular fast, irregular, missed beat or extra beat, forceful pounding), the discriminating history (sudden versus gradual onset and offset, polyuria after termination pointing to SVT, exercise provocation pointing to VT or structural disease, the family history of sudden death pointing to a channelopathy), the cardiovascular and thyroid examination, the mandatory 12-lead ECG interpretation (AF, SVT, VT, long QT, WPW delta wave, Brugada pattern, LVH, ischaemia), the tiered ambulatory ECG strategy matched to symptom frequency (Holter for daily, event monitor for weekly, implantable loop recorder for monthly or rarer), the echocardiogram for structural disease, the electrophysiology study, and the cause-directed management (vagal manoeuvres, AV nodal blockers and catheter ablation for SVT, rate or rhythm control and anticoagulation for AF, urgent cardiology referral and ICD for VT, specialist evaluation for the channelopathies and cardiomyopathies) — with the DCE long-case and short-case presentation templates, the examiner discussion questions, and the classic exam traps.

Open

high

Undifferentiated Presentations Abdominal Pain

Consultant-physician depth guide to Undifferentiated Presentations Abdominal Pain for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

high

Undifferentiated Weight Loss — A Systematic Diagnostic Approach

Consultant-physician-depth guide to the diagnostic approach to the patient with involuntary weight loss of unknown cause. Covers the definition of clinically significant loss (greater than 5 per cent of body weight in 6 months), the two first-minute branch points (intentional versus involuntary; appetite preserved versus lost), the seven-category differential (malignancy — GI, lung, haematological, prostate, ovarian; endocrine — hyperthyroidism, new-onset type 1 diabetes, adrenal insufficiency; GI — coeliac, chronic pancreatitis, IBD, SIBO, dysphagia, obstruction; chronic infection — TB, HIV, endocarditis, osteomyelitis; psychiatric — depression, anorexia nervosa, dementia; drugs — metformin, SGLT2i, topiramate, levothyroxine excess, chemotherapy; social), the two-tier investigation strategy (Tier 1 bloods plus CXR and ultrasound, Tier 2 CT CAP and endoscopy), the Hernandez prediction score for malignancy, the Metalidis evidence supporting observation after a normal workup, the Fearon cancer cachexia consensus, the nutritional assessment (MUST, MNA) and the management ladder (oral supplements, enteral, parenteral), the refeeding syndrome, and the exam traps that cost marks.

Open

high

Urticaria and Angioedema

Consultant-physician guide to urticaria and angioedema: the lesion-duration rule (transient wheals less than 24 hours equals urticaria; persistent lesions with purpura equal urticarial vasculitis), the acute-versus-chronic classification (chronic spontaneous urticaria CSU as a mast-cell autoimmune disease), the pivotal angioedema branch point (with urticaria equals histamine-mediated; without urticaria equals bradykinin-mediated — hereditary angioedema HAE, ACE inhibitor, acquired C1-INH deficiency), the four-step EAACI treatment ladder (standard-dose H1, up to 4-fold H1, omalizumab, ciclosporin), the acute and prophylactic management of HAE (C1-INH concentrate, icatibant, lanadelumab), and the absolute rules that HAE does NOT respond to adrenaline and ACE inhibitors are never rechallenged.

Open

Domain

renal

18

high

Acid-Base Disorders

Consultant-physician-depth guide to systematic acid-base interpretation and management — the six-step algorithm (pH, primary disorder, compensation, anion gap, delta-delta, osmolar gap), high and normal anion gap metabolic acidoses (MUDPILES/GOLD MARK and renal tubular acidoses), metabolic alkalosis, respiratory acid-base disorders, and treatment principles. Structured for FRACP DWE and DCE preparation.

Open

high

Acute Kidney Injury

Consultant-physician-depth guide to acute kidney injury — KDIGO definition and staging, pre-renal/intrinsic/post-renal classification, pathophysiology, investigation strategy, management principles, RRT indications, nephrotoxic agents, drug dosing, and prognosis. Structured for FRACP DWE and DCE preparation.

Open

high

Chronic Kidney Disease

Consultant-physician-depth guide to chronic kidney disease — KDIGO definition and CGA staging, pathophysiology of nephron loss and progressive fibrosis, aetiology, complications (CKD-MBD, renal anaemia, acidosis, hyperkalaemia, cardiovascular risk), progression-slowing therapy (RAAS blockade, SGLT2 inhibitors, finerenone, blood pressure control), dialysis preparation, transplant workup, conservative care, and drug dosing. Structured for FRACP DWE and DCE preparation.

Open

high

Diabetic Kidney Disease

Consultant-physician-depth guide to diabetic kidney disease (DKD) — the leading cause of end-stage kidney disease worldwide. Covers the hyperglycaemia to AGE to fibrosis pathophysiology, Mogensen five-stage natural history, screening with annual albumin-to-creatinine ratio, evidence-based management (SGLT2 inhibitors per CREDENCE/DAPA-CKD/EMPA-KIDNEY, ACEi/ARB per RENAAL/IDNT, finerenone per FIDELIO-DKD, multifactorial intervention per Steno-2), normoalbuminuric DKD, and renal biopsy indications. Structured for FRACP DWE and DCE preparation.

Open

high

Electrolyte Disorders: Calcium, Magnesium and Phosphate

Consultant-physician-depth guide to divalent ion disorders — corrected versus ionised calcium, the PTH-first hypercalcaemia workup and severe hypercalcaemia sequence, asymptomatic primary hyperparathyroidism decisions, post-surgical hypocalcaemia and acute tetany management, magnesium as the hidden blocker of potassium and calcium correction, torsades, CKD-MBD, tumor lysis and refeeding syndrome — structured for FRACP DWE and DCE preparation.

Open

high

Glomerulonephritis (Nephritic Spectrum)

Consultant-physician-depth guide to glomerulonephritis — nephritic syndrome, RPGN classification (anti-GBM, immune complex, pauci-immune/ANCA), IgA nephropathy (Oxford MEST-C), post-streptococcal GN, lupus nephritis (ISN/RPS), pulmonary-renal syndromes, complement interpretation, biopsy immunofluorescence, and evidence-based immunosuppression. Structured for FRACP DWE and DCE preparation.

Open

high

Hypertensive Nephrosclerosis and Renovascular Disease

Consultant-physician-depth guide to renovascular hypertension and hypertensive nephrosclerosis — when to hunt for secondary hypertension, renin-angiotensin physiology (one-clip vs two-clip), atherosclerotic renal artery stenosis versus fibromuscular dysplasia, the imaging sequence, the CORAL/ASTRAL evidence for medical-therapy-first, defined revascularisation subsets, malignant hypertension, and the biopsy distinction — structured for FRACP DWE and DCE preparation.

Open

high

Kidney Transplantation

Consultant-physician-depth guide to kidney transplantation — the indications (ESKD from any cause, refer for workup once the eGFR is below 20), the donor types (deceased donor DBD versus DCD, living donor, pre-emptive), the contraindications and workup, the immunosuppression regimen (induction with basiliximab or anti-thymocyte globulin; maintenance tacrolimus plus mycophenolate plus steroid), the surgical and medical complications (rejection classified by mechanism, the infection timeline, malignancy including PTLD and skin cancer, CNI nephrotoxicity, recurrent disease, NODAT, cardiovascular disease), and pregnancy after transplant. Structured for FRACP DWE and DCE preparation.

Open

high

Nephrolithiasis

Consultant-physician-depth guide to nephrolithiasis — stone types (calcium oxalate, calcium phosphate, uric acid, struvite, cystine), epidemiology, risk factors, pathophysiology (Randall plaque, supersaturation), clinical presentation of renal colic, investigation strategy (non-contrast CT KUB, ultrasound, metabolic evaluation), acute management (NSAIDs, medical expulsive therapy, ESWL, ureteroscopy, PCNL), prevention (fluid, diet, thiazides, citrate, allopurinol), and systemic associations. Structured for FRACP DWE and DCE, MRCP, and ABIM preparation.

Open

high

Nephrotic Syndrome

Consultant-physician-depth guide to nephrotic syndrome — definition (proteinuria greater than 3.5 g/day, hypoalbuminaemia, oedema, hyperlipidaemia), podocyte and slit-diaphragm pathophysiology, cause-by-age differential (minimal change disease, FSGS, membranous nephropathy with PLA2R antibody, membranoproliferative GN; secondary diabetic nephropathy, amyloidosis, lupus nephritis, viral-associated, malignancy-associated), complications (renal vein thrombosis, encapsulated-organism infection, hyperlipidaemia, AKI), investigation pathway (24-hour protein/PCR, biopsy, PLA2R antibody, viral and amyloid screens) and management (ACEi/ARB, cause-specific immunosuppression including rituximab for membranous — MENTOR and GEMRITUX). Structured for FRACP DWE and DCE preparation.

Open

high

Polycystic Kidney Disease (ADPKD)

Consultant-physician-depth guide to autosomal dominant polycystic kidney disease — PKD1 versus PKD2 genetics and natural history, ultrasound and genetic diagnosis, progression assessment with htTKV and the Mayo Imaging Classification, HALT-PKD blood-pressure targets, tolvaptan selection and its liver monitoring, extrarenal disease with selective aneurysm screening, cyst complications, ESKD and transplantation, and family counselling — structured for FRACP DWE and DCE preparation.

Open

high

Potassium Disorders — Hyperkalaemia and Hypokalaemia

Consultant-physician-depth guide to potassium homeostasis and its two emergencies. Covers hyperkalaemia (K+ above 5.5): the renal and pharmacological causes (AKI, CKD, RAAS inhibitors, K-sparing diuretics, Addison's, rhabdomyolysis, tumour lysis, acidosis), the ECG progression from peaked T waves through PR prolongation and QRS widening to sine wave and cardiac arrest, and emergency management with calcium gluconate for membrane stabilisation, insulin-dextrose and salbutamol to shift K+ intracellularly, bicarbonate in acidosis, the potassium binders (patiromer, sodium zirconium cyclosilicate, resonium) and dialysis. Covers hypokalaemia (K+ below 3.5): the GI and renal causes, diuretics, Bartter and Gitelman syndromes, Cushing and Conn syndromes, alkalosis, insulin, and refractory hypomagnesaemia; the clinical features of weakness, cramps, and U waves with QT prolongation; oral versus IV replacement with the maximum 10 to 20 mmol/h central-line rate; and the 24h urine potassium, renin/aldosterone and acid-base workup. Structured for FRACP DWE and DCE preparation.

Open

medium

Renal Cell Carcinoma AND Urothelial Malignancy

Consultant-physician depth guide to Renal Cell Carcinoma AND Urothelial Malignancy for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

high

Renal Replacement Therapy: Haemodialysis and Peritoneal Dialysis

Consultant-physician-depth guide to renal replacement therapy — the transplant-first landscape, IDEAL and symptom-based dialysis initiation, haemodialysis versus peritoneal dialysis selection by patient rather than superiority, fistula-first access and its complications, PD peritonitis diagnosis to catheter removal, the cardiovascular burden of dialysis, urgent starts, pregnancy, the frail elderly, conservative care as an active choice, and the holistic bundle — structured for FRACP DWE and DCE preparation.

Open

medium

Renal Tubular Acidoses AND Inherited Tubular Disorders

Consultant-physician depth guide to Renal Tubular Acidoses AND Inherited Tubular Disorders for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

high

Sodium Disorders — Hyponatraemia and Hypernatraemia

Consultant-physician-depth guide to sodium and water homeostasis. Covers hyponatraemia (the commonest inpatient electrolyte disorder): symptom-stratified urgency, volume-status classification, serum and urine osmolality with urine sodium interpretation, severe symptomatic management with 3% hypertonic saline boluses, the 8-10 mmol/L in 24 hours correction ceiling and osmotic demyelination syndrome, SIADH, and the euvolaemic/hypervolaemic differentials. Covers hypernatraemia as a water-deficit state: central versus nephrogenic diabetes insipidus, the water deprivation test and copeptin, free water deficit calculation, and slow oral or D5W correction over 48-72 hours. Structured for FRACP DWE and DCE preparation.

Open

high

Tubulointerstitial Disease

Consultant-physician-depth guide to acute and chronic interstitial nephritis — AIN as the great AKI mimic, the unreliability of the allergic triad, culprit drug classes (antibiotics, PPIs, NSAIDs, checkpoint inhibitors), urine clues and the limits of eosinophiluria, biopsy triggers, the observational evidence for corticosteroids, checkpoint-inhibitor AIN, TINU, chronic TIN (analgesic, lithium, aristolochic acid), recovery and CKD risk — structured for FRACP DWE and DCE preparation.

Open

medium

Urinary Tract Infection AND Complicated UTI Pyelonephritis

Consultant-physician depth guide to urinary tract infection and complicated UTI/pyelonephritis — IDSA 2010 cystitis and pyelonephritis guidance, uncomplicated versus complicated distinction, acute pyelonephritis 7-day versus 14-day therapy, asymptomatic and catheter-associated bacteriuria, pregnancy and prostatitis, fluoroquinolone safety (aortic aneurysm, dysglycaemia), emphysematous and xanthogranulomatous pyelonephritis, sepsis from urinary source, antibiotic stewardship and resistance. Structured for FRACP DWE/DCE, MRCP and ABIM preparation.

Open

Domain

haematological

15

high

Acute Leukaemia

Consultant-physician-depth guide to acute myeloid (AML) and acute lymphoblastic leukaemia (ALL) for FRACP DWE and DCE — AML-defining genetic events, APL as an emergency, 7+3 induction versus venetoclax combinations, ELN 2022 risk stratification, paediatric-inspired ALL and measurable residual disease.

Open

high

Anaemia — Systematic Workup

Consultant-physician-depth guide to the systematic investigation of anaemia. Covers MCV-based classification (microcytic, normocytic, macrocytic), the reticulocyte count as kinetic discriminator, iron-studies interpretation, the iron deficiency workup in adults (mandatory GI source search), haemolytic anaemia classification, blood-film morphology, transfusion thresholds, and the management of each major cause. Structured for FRACP DWE and DCE preparation.

Open

medium

Bleeding Disorders AND Thrombocytopenia

Consultant-physician depth guide to bleeding disorders and thrombocytopenia — ITP (ASH 2019, international consensus 2019), TTP and the PLASMIC score, ADAMTS13, caplacizumab, DIC (ISTH 2025 update), atypical HUS and complement, von Willebrand disease, hemophilia A with emicizumab, heparin-induced thrombocytopenia, and the tourniquet test that distinguishes platelet versus coagulation defects. Structured for FRACP DWE/DCE, MRCP and ABIM preparation.

Open

high

Chronic Leukaemia and Myeloid Neoplasms

Consultant-physician guide to the chronic leukaemias and related myeloid neoplasms — the indolent clonal disorders that dominate outpatient haematology. Covers chronic lymphocytic leukaemia (the commonest leukaemia in the Western world; clonal CD5-positive, CD19-positive, CD23-positive B cells; Rai and Binet staging; watch and wait for early asymptomatic disease; chemoimmunotherapy with FCR or BR for fit patients; novel agents ibrutinib, venetoclax and obinutuzumab; autoimmune haemolytic anaemia, ITP, infection and Richter transformation), chronic myeloid leukaemia (the BCR-ABL1 t(9;22) Philadelphia chromosome; chronic, accelerated and blast phases; imatinib, dasatinib, nilotinib, bosutinib and ponatinib; BCR-ABL1 transcript monitoring by qPCR; the T315I gatekeeper mutation; treatment-free remission; pregnancy), and overviews of the myeloproliferative neoplasms (polycythaemia vera, essential thrombocythaemia, myelofibrosis) and myelodysplastic syndrome (IPSS-R risk stratification, azacitidine, luspatercept and lenalidomide for del(5q)). Structured for FRACP DWE and DCE, MRCP, and ABIM preparation.

Open

high

Coagulation Disorders — Bleeding, Thrombosis and the Abnormal Coagulation Screen

Consultant-physician-depth guide to coagulation disorders for FRACP DWE and DCE. Covers the coagulation cascade (intrinsic, extrinsic, common pathways), inherited bleeding disorders (haemophilia A, haemophilia B, von Willebrand disease), acquired coagulopathies (DIC, liver disease, warfarin, massive transfusion), antiphospholipid syndrome, thrombocytopenia (ITP, HIT, TTP/HUS), mixing study interpretation, and the systematic investigation of the abnormal coagulation screen.

Open

high

Haematological Investigation Blood Film Marrow Coagulation Tests

Consultant-physician depth guide to Haematological Investigation Blood Film Marrow Coagulation Tests for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

high

Haematopoietic Stem Cell Transplantation

Consultant-physician-depth guide to autologous and allogeneic haematopoietic stem cell transplantation for FRACP DWE and DCE — mobilisation and harvest, conditioning intensity, engraftment, and the timeline of complications from mucositis and veno-occlusive disease through acute and chronic GVHD to secondary malignancy and endocrine late effects.

Open

high

Haemolytic Anaemia

Consultant-physician depth guide to Haemolytic Anaemia for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

high

Iron Deficiency

Consultant-physician-depth guide to iron deficiency — iron studies interpretation with the ferritin acute-phase caveat, absolute versus functional deficiency, the GI malignancy workup rule, coeliac serology, oral and IV iron with the alternate-day dosing evidence, and iron in heart failure, CKD, IBD and restless legs — structured for FRACP DWE and DCE preparation.

Open

high

Lymphoma — Hodgkin and Non-Hodgkin

Consultant-physician-depth guide to Hodgkin and non-Hodgkin lymphoma for FRACP DWE and DCE — Reed-Sternberg biology, Ann Arbor and Lugano staging, ABVD and PET-adapted therapy, the International Prognostic Score, DLBCL with R-CHOP and the IPI, follicular lymphoma and FLIPI, Burkitt emergencies, primary CNS lymphoma, marginal zone and mantle cell subtypes, CAR-T therapy for relapsed disease, and the Deauville response system.

Open

high

Multiple Myeloma

Consultant-physician-depth guide to multiple myeloma for FRACP DWE and DCE — IMWG diagnostic criteria, the CRAB and biomarker myeloma-defining events, MGUS versus smouldering versus active disease, cast nephropathy and the myeloma-defining free-light-chain ratio, R-ISS staging, transplant-eligible VRd induction with autologous transplant and lenalidomide maintenance, transplant-ineligible daratumumab-based regimens, proteasome inhibitors and anti-CD38 therapy, and supportive care including bisphosphonates and cord-compression emergencies.

Open

medium

Myelodysplastic Syndromes

Consultant-physician depth guide to Myelodysplastic Syndromes for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

medium

Myeloproliferative Neoplasms

Consultant-physician depth guide to Myeloproliferative Neoplasms for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

high

Thrombophilia and Venous Thromboembolism

Consultant-physician-depth guide to inherited and acquired thrombophilia and venous thromboembolism (VTE) for FRACP DWE and DCE — Factor V Leiden and prothrombin G20210A, protein C/S and antithrombin deficiency, antiphospholipid syndrome (lupus anticoagulant, anticardiolipin, beta-2 glycoprotein I), when to test and when not to test, DVT diagnosis (Wells score, D-dimer, compression ultrasound), DOACs first-line, warfarin for APS, LMWH for pregnancy and cancer, HIT (4T score, PF4 antibody), cerebral and splanchnic vein thrombosis, and the TRAPS, EINSTEIN-CHOICE, SELECT-D, Hokusai-CANVAS and Caravaggio trials.

Open

high

Transfusion Medicine

Consultant-physician-depth guide to blood component therapy — restrictive transfusion thresholds and their trial evidence, platelet/plasma/cryoprecipitate indications, acute transfusion reactions with the TACO–TRALI discriminator, massive transfusion, and transfusion safety — structured for FRACP DWE and DCE preparation.

Open

Domain

hepatic

5

high

Acute Liver Failure

Consultant-physician-depth guide to acute liver failure — the definition (encephalopathy and coagulopathy within 26 weeks, without pre-existing liver disease), the causes by category (paracetamol, idiosyncratic drug, viral, autoimmune, Wilson disease, ischaemic, Budd-Chiari, pregnancy-related, mushroom poisoning), the King's College Criteria for transplant (paracetamol versus non-paracetamol), the full ICU management algorithm, and the complications with cerebral oedema as the leading cause of death. Structured for FRACP DWE and DCE preparation.

Open

high

Autoimmune Liver Disease

Consultant-physician-depth guide to the three major autoimmune liver diseases — primary biliary cholangitis (AMA-positive, cholestatic LFTs, florid duct lesion, ursodeoxycholic acid ± obeticholic acid), primary sclerosing cholangitis (IBD association, beaded cholangiogram, cholangiocarcinoma and colorectal cancer risk, no effective medical therapy, ERCP for dominant strictures) and autoimmune hepatitis (interface hepatitis, high IgG, prednisolone plus azathioprine), with the AIH-PBC and AIH-PSC overlap syndromes, the diagnostic algorithm for abnormal LFTs, and the transplant indications. Structured for FRACP DWE and DCE preparation.

Open

high

Chronic Liver Disease and Cirrhosis

Consultant-physician-depth guide to chronic liver disease and cirrhosis — aetiology, fibrosis pathophysiology, the four decompensating events, and staging-driven management from primary prophylaxis to transplant assessment. Structured for FRACP DWE and DCE preparation.

Open

high

Hepatocellular Carcinoma

Consultant-physician guide to hepatocellular carcinoma — the cirrhosis-driven malignancy whose entire management hangs on the Barcelona Clinic Liver Cancer (BCLC) staging system. Covers the at-risk populations requiring six-monthly surveillance (all cirrhosis, selected chronic HBV without cirrhosis), LI-RADS imaging-based diagnosis without biopsy in the cirrhotic liver, BCLC stage-by-stage treatment allocation (resection, ablation, transplant within Milan criteria, TACE, and the systemic therapy ladder from atezolizumab-bevacizumab through sorafenib, lenvatinib and second-line TKIs), management of the underlying liver disease, and the prognosis by treatment modality. Structured for FRACP DWE and DCE, MRCP, and ABIM preparation.

Open

high

Viral Hepatitis (HAV, HBV, HCV, HDV, HEV)

Consultant-physician-depth guide to the five hepatotropic viruses — acute versus chronic hepatitis, HBV serology interpretation, the four phases of chronic HBV, HCV DAA therapy, HDV and HEV, acute liver failure, and hepatocellular carcinoma surveillance. Structured for FRACP DWE and DCE preparation.

Open

Domain

gastrointestinal

13

high

Acute Pancreatitis

Consultant-physician-depth guide to acute pancreatitis — premature intracellular trypsin activation and the I GET SMASHED aetiology, classic epigastric pain radiating to the back, lipase above 3x ULN as the diagnostic anchor, the Revised Atlanta Classification severity tiers, BISAP and Ranson scoring, goal-directed fluid resuscitation after the WATERFALL trial, early enteral feeding within 24 to 48 hours, ERCP for cholangitis only, the step-up approach for infected necrosis after PANTER, and same-admission cholecystectomy for gallstone pancreatitis. Structured for FRACP DWE and DCE preparation.

Open

high

Chronic Pancreatitis

Consultant-physician-depth guide to chronic pancreatitis — the irreversible fibroinflammatory destruction of pancreatic parenchyma, the TIGAR-O mechanistic aetiology (alcohol 70 per cent, hereditary PRSS1/SPINK1/CFTR, autoimmune IgG4-related type 1, tropical calcific, obstructive), the clinical triad of chronic epigastric pain, steatorrhoea from exocrine insufficiency, and type 3c brittle diabetes, the investigations (faecal elastase below 200, CT calcification, MRCP ductal anatomy, EUS Rosemont early changes), the analgesic ladder and endoscopic-surgical drainage (Puestow, Frey, Beger, Whipple, Cahen trial), pancreatic enzyme replacement, and pancreatic cancer surveillance. Structured for FRACP DWE and DCE preparation.

Open

high

Colorectal Cancer

Consultant-physician guide to colorectal cancer — the third most common cancer worldwide, whose prevention rests on the adenoma-carcinoma sequence and whose treatment hangs on TNM/Dukes staging. Covers the molecular pathway (APC, KRAS, TP53 and the microsatellite instability/Lynch pathway), risk factors (age, family history, IBD, diet, the hereditary syndromes), FIT-based screening and surveillance intervals, clinical presentation by tumour site, the surgical principles (colectomy with lymph node dissection, total mesorectal excision for rectal cancer), adjuvant chemotherapy by stage (FOLFOX/CAPOX for stage III, selective stage II), metastatic management (chemotherapy plus biologic by RAS/MSI status, metastasectomy, pembrolizumab for MSI-high), and the hereditary syndromes (Lynch, FAP, MUTYH, Peutz-Jeghers, juvenile polyposis). Structured for FRACP DWE and DCE, MRCP, and ABIM preparation.

Open

medium

Functional GI Disorders

Consultant-physician depth guide to Functional GI Disorders for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

medium

Gallstone Disease AND Biliary Pathology

Consultant-physician depth guide to Gallstone Disease AND Biliary Pathology for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

high

Gastrointestinal Bleeding

Consultant-physician-depth guide to acute upper and lower gastrointestinal bleeding — risk stratification (Glasgow-Blatchford, Rockall), resuscitation, restrictive transfusion, endoscopic therapy, variceal management and obscure GI bleed — structured for FRACP DWE and DCE preparation.

Open

medium

GI Investigation Endoscopy Capsule Liver Biopsy Elastography

Consultant-physician depth guide to GI Investigation Endoscopy Capsule Liver Biopsy Elastography for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

high

Inflammatory Bowel Disease

Consultant-physician-depth guide to inflammatory bowel disease — pathophysiology (NOD2, ATG16L1, Th1/Th17, TNF, IL-12/23), UC versus Crohn's discrimination, clinical phenotypes, extraintestinal manifestations, investigation strategy, stepwise biologic and surgical management, colitis-associated neoplasia surveillance, and pregnancy. Structured for FRACP DWE and DCE preparation.

Open

medium

Liver Transplantation

Consultant-physician depth guide to Liver Transplantation for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

high

Malabsorption and Small Bowel Disease

Consultant-physician-depth guide to malabsorption and small bowel disease — the three-level pathophysiology (luminal maldigestion, mucosal absorption, and transport), the mucosal causes (coeliac disease with anti-tTG IgA and anti-endomysial serology, duodenal Marsh classification, gluten-free diet, refractory coeliac, dermatitis herpetiformis, and selective IgA deficiency), tropical sprue, Crohn disease, eosinophilic gastroenteritis, amyloidosis, and Whipple disease (Tropheryma whipplei), the digestive causes (chronic pancreatic exocrine insufficiency, bile salt malabsorption, and SIBO), the structural causes (short bowel syndrome, blind loop, fistula, strictures), and the structured investigation pathway (FBC anaemia type, albumin and alpha-1-antitrypsin clearance, coeliac serology, faecal calprotectin and elastase, SeHCAT, hydrogen breath test, OGD with biopsy, capsule endoscopy, CT or MR enterography). Structured for FRACP DWE and DCE preparation.

Open

medium

Nutrition IN Liver AND GI Disease

Consultant-physician depth guide to Nutrition IN Liver AND GI Disease for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

high

Obstructive (Surgical) Jaundice

Consultant-physician-depth guide to obstructive (surgical) jaundice — bilirubin above 50 micromol per litre with predominant conjugated hyperbilirubinaemia, elevated alkaline phosphatase and gamma-GT, pale stools, dark urine, and pruritus. Causes classified by the level of obstruction: extrahepatic (choledocholithiasis as the most common cause, pancreatic head cancer, cholangiocarcinoma, ampullary cancer, biliary stricture, parasitic obstruction, biliary atresia, Mirizzi syndrome, pancreatitis) and intrahepatic cholestasis (drugs, PBC, PSC, viral hepatitis, sepsis, Dubin-Johnson and Rotor, intrahepatic cholestasis of pregnancy). The diagnostic approach from history (biliary colic versus painless jaundice, weight loss, Charcot triad) and examination (Courvoisier sign, scratch marks, asterixis) through investigations (LFT pattern, GGT, coagulation, CA 19-9, ultrasound first-line, MRCP gold-standard, CT for pancreatic mass, EUS-FNA, ERCP therapeutic). Management of the underlying cause, biliary drainage, the Tokyo Guidelines 2018 for cholangitis, pre-operative optimisation with vitamin K, and palliative care for advanced malignancy. Structured for FRACP DWE and DCE, MRCP, and ABIM preparation.

Open

high

Oesophageal Disorders

Consultant-physician-depth guide to oesophageal disorders — the dysphagia discrimination framework, GORD and the refractory-reflux workup, Barrett's surveillance and endoscopic eradication, eosinophilic oesophagitis from PPI-first to dupilumab, achalasia subtypes and subtype-matched treatment, oesophageal cancer staging and neoadjuvant therapy, and the oesophageal emergencies — structured for FRACP DWE and DCE preparation.

Open

Domain

endocrine

14

high

Adrenal Disorders

Consultant-physician-depth guide to adrenal disorders — adrenal physiology, Addison's disease (primary adrenal insufficiency) and adrenal crisis, secondary adrenal insufficiency, Cushing syndrome, primary aldosteronism (Conn syndrome), phaeochromocytoma, and the adrenal incidentaloma — structured for FRACP DWE and DCE, MRCP and ABIM preparation.

Open

medium

Adrenal Incidentaloma AND Workup

Consultant-physician depth guide to Adrenal Incidentaloma AND Workup for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

high

Calcium and Bone Disorders

Consultant-physician-depth guide to calcium homeostasis and bone disorders — hypercalcaemia (primary hyperparathyroidism, malignancy-associated, granulomatous, drug-induced), hypocalcaemia (post-surgical hypoparathyroidism, autoimmune, vitamin D deficiency, CKD, hypomagnesaemia), osteoporosis (DEXA, FRAX, bisphosphonates, denosumab, teriparatide, anabolic therapy, drug holidays), and osteomalacia (vitamin D deficiency, Looser zones) — structured for FRACP DWE and DCE preparation.

Open

high

Diabetes Mellitus

Consultant-physician-depth guide to diabetes mellitus — pathophysiology, classification, diagnosis, glycaemic target individualisation, the modern pharmacological hierarchy for type 2, insulin therapy, microvascular and macrovascular complications, diabetic foot, glycaemic emergencies, diabetes in pregnancy, and diabetes technology — structured for FRACP DWE and DCE preparation.

Open

high

Diabetic Ketoacidosis and Hyperosmolar Hyperglycaemic State

Consultant-physician-depth guide to the two hyperglycaemic emergencies — diagnostic criteria for DKA (ketonaemia above 3 mmol/L or ketonuria 3+, glucose above 11, pH below 7.3, bicarbonate below 15) and HHS (glucose above 33, osmolality above 320, no significant ketosis, pH above 7.3), pathophysiology of insulin deficiency and ketogenesis, precipitant recognition, and the full JBDS management protocol (fluid resuscitation, fixed-rate insulin infusion 0.1 units/kg/hour, potassium replacement, dextrose switch, resolution criteria) and HHS-specific differences. Structured for FRACP DWE and DCE preparation.

Open

high

Disorders OF Sodium AND Water Homeostasis

Consultant-physician depth guide to Disorders OF Sodium AND Water Homeostasis for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

high

Hypoglycaemia

Consultant-physician depth guide to hypoglycaemia for FRACP DWE/DCE — Whipple triad and the 72-hour supervised fast, insulinoma diagnosis and the diagnostic cut-offs, non-islet cell tumour hypoglycaemia (IGF-2), factitious and sulfonylurea-induced hypoglycaemia, congenital hyperinsulinism (KCNJ11/ABCC8), hypoglycaemia-associated autonomic failure in diabetes, the Endocrine Society inpatient guideline, the basal-bolus evidence (RABBIT 2), and the 15/15 rule and glucagon rescue. Structured for FRACP DWE/DCE, MRCP and ABIM preparation.

Open

medium

Metabolic Bone Disease AND Vitamin D Disorders

Consultant-physician depth guide to Metabolic Bone Disease AND Vitamin D Disorders for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

medium

Multiple Endocrine Neoplasia

Consultant-physician depth guide to multiple endocrine neoplasia — MEN1 (MENIN mutation, primary hyperparathyroidism, pancreatic neuroendocrine tumours including gastrinoma and insulinoma, pituitary adenoma) and MEN2 (RET proto-oncogene, medullary thyroid cancer, pheochromocytoma, primary hyperparathyroidism), ATA genotype-risk stratification, prophylactic thyroidectomy timing, calcitonin screening, biochemical surveillance, and cascade genetic testing. Structured for FRACP DWE and DCE preparation.

Open

high

Pituitary Disease

Consultant-physician-depth guide to pituitary disease — anatomy and physiology, pituitary adenoma classification, prolactinoma, acromegaly, Cushing disease, non-functioning adenoma, hypopituitarism, pituitary apoplexy, craniopharyngioma, and diabetes insipidus — structured for FRACP DWE and DCE preparation.

Open

medium

Reproductive Endocrinology

Consultant-physician depth guide to Reproductive Endocrinology for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

high

Thyroid Disorders

Consultant-physician-depth guide to thyroid disorders — hyperthyroidism (Graves disease, toxic multinodular goitre, toxic adenoma, thyroiditis, amiodarone), thyroid storm, hypothyroidism (Hashimoto thyroiditis, post-treatment, iodine, drugs), myxoedema coma, thyroid nodules (Bethesda classification) and thyroid cancer (papillary, follicular, medullary, anaplastic) — structured for FRACP DWE and DCE preparation.

Open

high

Thyroid Nodules AND Thyroid Cancer

Consultant-physician depth guide to Thyroid Nodules AND Thyroid Cancer for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

medium

Transgender Medicine AND Hormone Therapy

Consultant-physician depth guide to transgender medicine and gender-affirming hormone therapy — WPATH SOC 8 and Endocrine Society guidance, feminising (oestradiol plus anti-androgen) and masculinising (testosterone) regimens, pubertal suppression with GnRH analogues, cardiovascular and venous thromboembolism risk, bone health, cancer screening, HIV and mental health, surgical options and complications, and the physician's role in shared decision-making across the lifespan. Structured for FRACP DWE/DCE, MRCP and ABIM preparation.

Open

Domain

cardiovascular

20

medium

Adult Congenital Heart Disease

Consultant-physician depth guide to Adult Congenital Heart Disease for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

high

Anticoagulation and Antiplatelet Therapy (Physician-Managed)

Consultant-physician-depth guide to anticoagulant and antiplatelet prescribing — warfarin and the DOACs with doses and renal thresholds, VTE duration, mechanical valves, reversal agents, perioperative management, HIT, cancer-associated VTE, DAPT and triple therapy — structured for FRACP DWE and DCE preparation.

Open

medium

Aortic Disease

Consultant-physician depth guide to Aortic Disease for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

high

Arrhythmias and Conduction Disease

Consultant-physician-depth guide to tachy- and bradyarrhythmias — the stability rule, SVT and adenosine, AF rate/rhythm strategy and anticoagulation evidence, VT and Torsades, ICD primary prevention, heart block and pacing decisions, and conduction disease — structured for FRACP DWE and DCE preparation.

Open

high

Atrial Fibrillation

Consultant-physician-depth guide to atrial fibrillation — pathophysiology, classification, rate versus rhythm control, anticoagulation with CHA₂DS₂-VASc and DOACs, catheter ablation, and rapid ventricular response management — structured for FRACP DWE and DCE preparation.

Open

high

Cardiac Investigations

Consultant-physician-depth guide to cardiac investigations — echocardiography, stress testing, CT coronary angiography, coronary angiography, cardiac MRI, electrophysiology, implantable devices, and biomarkers — structured for FRACP DWE and DCE preparation.

Open

medium

Cardiac Tumours AND Systemic Manifestations OF Cardiac Disease

Consultant-physician depth guide to Cardiac Tumours AND Systemic Manifestations OF Cardiac Disease for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

high

Cardiomyopathies

Consultant-physician-depth guide to the four cardiomyopathy phenotypes — hypertrophic (HCM), dilated (DCM), arrhythmogenic RV (ARVC), and restrictive cardiomyopathy — with genetics, cardiac MRI interpretation, sudden cardiac death risk stratification, and the guideline-driven management of each, structured for FRACP DWE and DCE preparation.

Open

high

Cardiovascular Prevention and Rehabilitation

Consultant-physician-depth guide to cardiovascular prevention — absolute risk assessment, lipid targets and the statin-to-PCSK9 ladder, statin intolerance and the nocebo problem, triglycerides, Lp(a) and familial hypercholesterolaemia, lifestyle prescription with numbers, the post-ACS secondary prevention bundle, and cardiac rehabilitation — structured for FRACP DWE and DCE preparation.

Open

high

Coronary Artery Disease

Consultant-physician-depth guide to coronary artery disease — atherosclerotic pathophysiology, stable angina, the ACS spectrum (UA/NSTEMI/STEMI), troponin and ECG interpretation, acute reperfusion strategy, and secondary prevention — structured for FRACP DWE and DCE preparation.

Open

high

ECG Interpretation — Physician Level

Consultant-physician-depth guide to systematic 12-lead ECG interpretation: rate, rhythm, axis, intervals, chamber enlargement, conduction disease, ischaemia/infarction patterns, electrolyte and drug effects, arrhythmias, and inherited channelopathies — structured for FRACP DWE and DCE preparation.

Open

high

Heart Failure

Consultant-physician-depth guide to heart failure diagnosis, classification, investigation, and the four pillars of guideline-directed medical therapy (GDMT) for HFrEF — structured for FRACP DWE and DCE preparation.

Open

high

Hypertension

Consultant-physician-depth guide to hypertension — definition and classification across ANZ/UK/US guidelines, pathophysiology, secondary causes workup, target organ damage, lifestyle and pharmacological management, resistant hypertension, and hypertensive emergencies. Structured for FRACP DWE and DCE preparation.

Open

high

Infective Endocarditis

Consultant-physician-depth guide to infective endocarditis — pathogenesis, Modified Duke criteria, microbiology, antibiotic therapy (native vs prosthetic valve), surgical indications, prophylaxis, and complications — structured for FRACP DWE and DCE preparation.

Open

high

Pericardial Disease

Consultant-physician-depth guide to the pericardial syndromes — acute pericarditis, pericardial effusion and cardiac tamponade, constrictive pericarditis, and recurrent pericarditis — structured for FRACP DWE and DCE preparation.

Open

high

Pulmonary Hypertension

Consultant-physician-depth guide to pulmonary hypertension — the updated ESC/ERS 2022 haemodynamic definition (mPAP above 20 mmHg), the WHO five-group clinical classification, Group 1 PAH workup and combination therapy, CTEPH operability and riociguat, and the three-strata risk model — structured for FRACP DWE and DCE, MRCP, and ABIM preparation.

Open

medium

Rheumatic Fever AND Rheumatic Heart Disease

Consultant-physician depth guide to rheumatic fever and rheumatic heart disease for FRACP DWE/DCE preparation — 2015 revised Jones criteria, group A streptococcal pharyngitis, secondary penicillin prophylaxis with benzathine penicillin G, mitral stenosis and percutaneous balloon mitral valvotomy, mechanical versus bioprosthetic valve choice, anticoagulation in pregnancy, AHA 2020 RHD scientific statement, and echocardiographic screening in endemic regions. Structured for FRACP DWE/DCE, MRCP and ABIM preparation.

Open

medium

Sudden Cardiac Death AND ICD CRT Therapy

Consultant-physician depth guide to sudden cardiac death and device therapy — SCD definitions and burden, primary-prevention ICD thresholds (MADIT-II, SCD-HeFT, DANISH), secondary-prevention AVID evidence, cardiac resynchronisation therapy (COMPANION, CARE-HF), inherited cardiomyopathies and channelopathies (HCM risk-SCD, ARVC Padua criteria, long QT and Brugada), VT ablation (VTACH/SMASH-VT), electrical storm, device interrogation, and deactivation at end of life. Structured for FRACP DWE/DCE, MRCP and ABIM preparation.

Open

high

Syncope

Consultant-physician-depth guide to syncope — the transient loss of consciousness from global cerebral hypoperfusion — using the 2018 ESC classification of reflex, orthostatic, and cardiac causes, with a directed investigation pathway from ECG to implantable loop recorder, risk stratification, and evidence-based management including physical counter-pressure manoeuvres, fludrocortisone, midodrine, and pacemaker therapy for selected patients.

Open

high

Valvular Heart Disease

Consultant-physician-depth guide to the four cardiac valves — aortic stenosis, aortic regurgitation, mitral stenosis, mitral regurgitation, tricuspid regurgitation, and prosthetic valves — structured for FRACP DWE and DCE preparation.

Open

Domain

pharmacological

15

high

Adverse Drug Reactions — Classification, Recognition and Management

Consultant-physician-depth guide to adverse drug reactions (ADRs): the Rawlins and Thompson ABCDEF classification, causality assessment (Naranjo), the high-yield severe reactions a physician must not miss (DRESS, SJS/TEN, drug-induced agranulocytosis and thrombocytopenia, DILI and Hy's Law, drug-induced interstitial lung disease, QT prolongation), Type E withdrawal syndromes, Type F treatment failure, Yellow Card and TGA reporting, and prevention through medication reconciliation and electronic alerts — structured for FRACP DWE and DCE preparation.

Open

high

Australian Envenomation — Snake, Spider and Marine

Consultant-physician-depth guide to Australian envenomation — the five major elapid snake groups (brown, tiger, taipan, death adder, black snake) and their clinical syndromes (neurotoxic, venom-induced consumption coagulopathy, myotoxic, renal, cardiovascular collapse), the pressure immobilisation bandage as first aid, the Snake Venom Detection Kit, monovalent and polyvalent antivenom selection and dosing, the critical VICC-versus-DIC distinction, funnel-web and red-back spider envenomation, and marine envenomation (box jellyfish, blue-ringed octopus, stonefish, sea snake). Structured for FRACP DWE and DCE preparation.

Open

high

Beta Blocker AND Calcium Channel Blocker Toxicity

Consultant-physician depth guide to Beta Blocker AND Calcium Channel Blocker Toxicity for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

high

Cardiac Glycoside

Consultant-physician depth guide to Cardiac Glycoside for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

medium

Iron Toxicity

Consultant-physician depth guide to Iron Toxicity for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

high

Lithium Toxicity

Consultant-physician guide to lithium toxicity — the narrow-therapeutic-index monovalent cation whose entirely renal elimination makes it vulnerable to dehydration, drug interactions (thiazides, ACE inhibitors, NSAIDs), and acute kidney injury. Covers the pharmacology (inositol depletion, GSK-3 inhibition, 0.6 to 1.0 mmol/L maintenance target, 0.8 to 1.2 for acute mania, toxicity above 1.5, severe above 2.5), the three clinical patterns (acute, acute-on-chronic, chronic), the clinical features by severity (mild: coarse tremor, gastrointestinal, ataxia, hyperreflexia; severe: seizures, coma, hyperthermia, QT prolongation, myoclonus), the chronic end-organ effects (nephrogenic diabetes insipidus, chronic interstitial nephritis, hypothyroidism, hyperparathyroidism, SILENT), and the management (stop lithium, aggressive IV saline, haemodialysis by EXTRIP criteria, post-dialysis rebound monitoring). Structured for FRACP DWE and DCE, MRCP, and ABIM preparation.

Open

high

Opioid Benzodiazepine AND Alcohol Withdrawal

Consultant-physician depth guide to withdrawal from alcohol, benzodiazepines and opioids for FRACP DWE/DCE preparation — pathophysiology of kindling and excitotoxicity, CIWA-Ar symptom-triggered benzodiazepine protocols, phenobarbital for benzodiazepine-resistant and severe alcohol withdrawal, delirium tremens and Wernicke prevention, the Clinical Opiate Withdrawal Scale (COWS), buprenorphine and methadone for opioid use disorder, naloxone reversal, long-term pharmacotherapy with naltrexone and acamprosate, and the Ashton-style benzodiazepine taper. Structured for FRACP DWE/DCE, MRCP and ABIM preparation.

Open

high

Paracetamol Toxicity

Consultant-physician-depth guide to paracetamol (acetaminophen) toxicity — CYP2E1 metabolism to NAPQI and glutathione depletion, the toxic dose in acute and staggered overdose, the four-stage clinical course, the Rumack-Matthew nomogram, the 21-hour N-acetylcysteine regimen, adverse reactions to NAC, and the King's College Criteria for transplant referral. Structured for FRACP DWE and DCE preparation.

Open

high

Pharmacokinetics in Organ Failure — Renal, Hepatic and Polypharmacy Dosing

Consultant-physician-depth guide to pharmacokinetic principles in organ failure — renal and hepatic dose adjustment, estimating renal function (Cockcroft-Gault and the 2021 CKD-EPI race-free equation with its limitations), the water-soluble vs lipid-soluble drug distinction, Child-Pugh hepatic dosing, therapeutic drug monitoring (vancomycin AUC, aminoglycoside extended-interval dosing, phenytoin free levels, digoxin, lithium), drug-induced organ failure, and polypharmacy in the elderly (Beers criteria, STOPP/START). Structured for FRACP DWE and DCE preparation.

Open

high

Poisoning — Approach, Decontamination and Antidotes

Consultant-physician-depth guide to the systematic approach to the poisoned patient — ABCDE resuscitation, toxidrome identification (sympathomimetic, anticholinergic, cholinergic, opioid, sedative-hypnotic), gastrointestinal decontamination (activated charcoal, whole bowel irrigation), enhanced elimination (urinary alkalinisation, multi-dose charcoal, haemodialysis), and the antidote reference table. Structured for FRACP DWE and DCE preparation.

Open

high

Salicylate Toxicity

Consultant-physician depth guide to Salicylate Toxicity for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

high

Serotonin Syndrome and Neuroleptic Malignant Syndrome

Consultant-physician-depth guide to the drug-induced hyperthermia syndromes — serotonin syndrome (excess serotonergic activity) and neuroleptic malignant syndrome (dopamine blockade) — including the clinical triad, the Hunter criteria, the SS-versus-NMS-versus-malignant-hyperthermia comparison, cyproheptadine and dantrolene pharmacology, and ICU supportive care, structured for FRACP DWE and DCE preparation.

Open

high

Therapeutic Drug Monitoring

Consultant-physician depth guide to Therapeutic Drug Monitoring for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

high

Toxic Alcohols

Consultant-physician depth guide to Toxic Alcohols for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

high

Tricyclic Antidepressant AND Sodium Channel Blocker Toxicity

Consultant-physician depth guide to Tricyclic Antidepressant AND Sodium Channel Blocker Toxicity for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

Domain

rheumatological

18

medium

Allergic Rhinitis AND Asthma

Consultant-physician depth guide to the united airway disease of allergic rhinitis and asthma — type 2 eosinophilic inflammation, ARIA classification, GINA stepwise therapy, intranasal and inhaled corticosteroids, SMART regimens, allergen immunotherapy (SLIT/SCIT), biologics (omalizumab, mepolizumab, benralizumab, dupilumab, tezepelumab), montelukast FDA boxed warning, EGPA differential, and pregnancy/frailty adjustments. Structured for FRACP DWE/DCE, MRCP and ABIM preparation.

Open

high

Antiphospholipid Syndrome

Consultant-physician depth guide to Antiphospholipid Syndrome for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

medium

Complement Deficiencies AND Recurrent Infections

Consultant-physician depth guide to complement deficiencies and recurrent infections — classical pathway defects (C1q, C1r/s, C2, C4) with autoimmune risk, lectin pathway defects with encapsulated bacteria, alternative pathway (factor D, factor P/properdin) with Neisseria and invasive meningococcal disease, terminal pathway C5-C9 with Neisseria, factor I and factor H deficiency with atypical HUS and C3 glomerulopathy, hereditary angioedema (C1-INH SERPING1) with acute and prophylactic therapy (C1-INH concentrate, icatibant, ecallantide, lanadelumab, berotralstat), vaccination strategies, and the workup of recurrent infection with low C3/C4. Structured for FRACP DWE/DCE, MRCP and ABIM preparation.

Open

high

Crystal Arthropathies

Consultant-physician depth guide to Crystal Arthropathies for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

medium

Drug Induced Rheumatological Disease AND Biologics Safety

Consultant-physician depth guide to Drug Induced Rheumatological Disease AND Biologics Safety for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

medium

Eosinophilic Disorders

Consultant-physician depth guide to Eosinophilic Disorders for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

high

Fibromyalgia and Chronic Widespread Pain

Consultant-physician-depth guide to fibromyalgia and chronic widespread pain — central sensitisation pathophysiology (amplified CNS pain processing, deficient descending inhibition, the neurotransmitter profile), chronic widespread musculoskeletal pain with fatigue, sleep disturbance and cognitive dysfunction, the cluster of central sensitivity syndromes, the 2016 ACR diagnostic criteria (WPI and SSS, abolition of tender points), the distinction from inflammatory and endocrine mimics, the non-pharmacological-first management (exercise, CBT, sleep hygiene, pacing) with symptom-targeted pharmacotherapy (amitriptyline, duloxetine, pregabalin), the explicit avoidance of opioids and glucocorticoids, and the multidisciplinary approach — structured for FRACP DWE and DCE preparation.

Open

high

IgG4-Related Disease

Consultant-physician-depth guide to IgG4-related disease for FRACP DWE and DCE — the one-disease-many-organs fibroinflammatory concept linking type 1 autoimmune pancreatitis (painless obstructive jaundice, sausage-shaped pancreas, steroid-responsive), IgG4-related sclerosing cholangitis (distinguish from PSC and cholangiocarcinoma), Mikulicz syndrome (sialadenitis and dacryoadenitis, distinguish from Sjogren), IgG4-related kidney disease (tubulointerstitial nephritis), retroperitoneal fibrosis (Ormond disease, ureteric obstruction), aortitis, lung disease, pachymeningitis and hypophysitis; the diagnostic approach built on histopathology (dense lymphoplasmacytic infiltrate, storiform fibrosis, obliterative phlebitis, IgG4-positive plasma cells with IgG4 to IgG ratio above 40 per cent), the 2019 ACR and EULAR classification criteria and the 2020 revised comprehensive diagnostic criteria; the correct use and limits of serum IgG4 (elevated in 60 to 70 per cent, falsely positive in pancreatobiliary cancer and asthma, normal IgG4 does not exclude the disease); and the treatment ladder — glucocorticoids first-line, rituximab for relapsing or multi-organ disease, mycophenolate or azathioprine for maintenance, and the critical distinction of the steroid-responsive inflammatory phase from the steroid-resistant fibrotic phase.

Open

medium

Immunological Investigation Immunoglobulins Complement Flow Cytometry

Consultant-physician depth guide to Immunological Investigation Immunoglobulins Complement Flow Cytometry for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

medium

Osteoarthritis

Consultant-physician depth guide to Osteoarthritis for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

high

Rheumatoid Arthritis

Consultant-physician-depth guide to rheumatoid arthritis — autoimmune synovitis pathophysiology (T-cell driven, B-cell antibodies, cytokine cascades, pannus formation), symmetrical small-joint polyarthritis with extra-articular manifestations, ACR/EULAR 2010 classification, treat-to-target management with conventional synthetic, biologic and targeted synthetic DMARDs, pre-biologic screening, and comorbidity management — structured for FRACP DWE and DCE preparation.

Open

high

Rheumatological Investigation Autoantibodies Imaging Synovial Fluid

Consultant-physician depth guide to Rheumatological Investigation Autoantibodies Imaging Synovial Fluid for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

high

SJ Gren S Syndrome AND Inflammatory Myopathies

Consultant-physician depth guide to SJ Gren S Syndrome AND Inflammatory Myopathies for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

high

Spondyloarthropathies

Consultant-physician-depth guide to the seronegative spondyloarthropathies — axial spondyloarthritis (ankylosing spondylitis, non-radiographic axSpA), psoriatic arthritis, reactive arthritis, and enteropathic arthritis — covering enthesitis-driven pathophysiology (HLA-B27, IL-23/IL-17 axis), inflammatory back pain recognition (Calin criteria, ASAS classification, MRI sacroiliitis), the modified New York criteria, BASDAI/BASFI/ASDAS, NSAIDs first-line, physiotherapy core, biologic DMARDs (TNF inhibitors, IL-17 inhibitors) and JAK inhibitors, plus extra-articular manifestations (uveitis, aortic regurgitation, apical fibrosis, amyloidosis) and the CASPAR/DAPSA framework for psoriatic arthritis — structured for FRACP DWE and DCE preparation.

Open

medium

Systemic Autoinflammatory Syndromes

Consultant-physician-depth guide to the systemic autoinflammatory syndromes for FRACP DWE and DCE — the innate-versus-adaptive immune framework, the hereditary recurrent fevers (familial Mediterranean fever with MEFV and colchicine prophylaxis and AA amyloidosis, TNF receptor-associated periodic syndrome with TNFRSF1A and prolonged fever, hyper-IgD syndrome with mevalonate kinase deficiency), the cryopyrin-associated periodic syndromes (CAPS spectrum of FCAS, Muckle-Wells and NOMID), adult-onset Still disease with the Yamaguchi criteria and elevated ferritin, Schnitzler syndrome with chronic urticaria and monoclonal IgM gammopathy, Behcet disease cross-referenced with the vasculitis topic, the diagnostic approach of pattern recognition plus a targeted genetic panel, and the treatment principle that IL-1 blockade is transformative for NLRP3-driven disease, HIDS, colchicine-resistant FMF, TRAPS, AOSD and Schnitzler syndrome.

Open

high

Systemic Lupus Erythematosus

Consultant-physician-depth guide to systemic lupus erythematosus (SLE) — loss of immune tolerance, type I interferon signature, autoantibody profiling (ANA, anti-dsDNA, anti-Smith, anti-Ro/La, antiphospholipid), multisystem clinical features, lupus nephritis (ISN/RPS classes I to VI), ACR/EULAR 2019 classification, antiphospholipid syndrome, pregnancy and neonatal lupus, and evidence-based immunosuppression from hydroxychloroquine to belimumab, anifrolumab and voclosporin. Structured for FRACP DWE and DCE preparation.

Open

high

Systemic Sclerosis (Scleroderma)

Consultant-physician-depth guide to systemic sclerosis for FRACP DWE and DCE — the three-hit pathophysiology, ACR/EULAR 2013 classification, limited versus diffuse cutaneous subtypes and their autoantibodies (anti-centromere, anti-Scl-70/topoisomerase I, anti-RNA polymerase III), multisystem organ involvement (Raynaud and nailfold capillaroscopy, oesophageal and small-bowel disease, NSIP-pattern interstitial lung disease, pulmonary arterial hypertension, scleroderma renal crisis), organ-based surveillance and management, the ACE-inhibitor first principle in renal crisis, mycophenolate and nintedanib for lung disease, and autologous stem cell transplant for severe early diffuse disease.

Open

high

The Systemic Vasculitides

Consultant-physician-depth guide to the systemic vasculitides for FRACP DWE and DCE — the Chapel Hill 2012 vessel-size classification, large vessel disease (giant cell arteritis and polymyalgia rheumatica with urgent steroids and tocilizumab, Takayasu arteritis in young Asian women), medium vessel disease (polyarteritis nodosa with microaneurysms, HBV association and mononeuritis multiplex, Kawasaki disease), ANCA-associated small vessel vasculitis (granulomatosis with polyangiitis with c-ANCA/PR3 and ENT-lung-kidney disease, microscopic polyangiitis with p-ANCA/MPO and renal-pulmonary disease, eosinophilic granulomatosis with polyangiitis with asthma and eosinophilia), immune complex small vessel vasculitis (cryoglobulinaemic vasculitis with HCV and low complement, IgA vasculitis in children with palpable purpura and glomerulonephritis), variable vessel vasculitis (Behcet disease), the diagnostic approach using biopsy, angiography, ANCA pattern and complement, and the treatment framework of steroids first-line, cyclophosphamide or rituximab for organ-threatening disease, plasma exchange for anti-GBM overlap and severe RPGN, and maintenance therapy with azathioprine, mycophenolate or methotrexate.

Open

Domain

infectious

16

high

Antimicrobial Stewardship and Resistance

Consultant-physician-depth guide to antimicrobial stewardship and resistance — the central principle that every antibiotic prescription has consequences, captured by the five rights (right drug, right dose, right route, right duration, right indication). Covers the mechanisms of resistance (intrinsic versus acquired; enzymatic inactivation, target modification, reduced permeability and efflux, bypass; plasmids, transposons, integrons; rpoB mutations in TB), the key resistant organisms and their first-line, alternative and last-resort agents (MRSA, VRE, ESBL Enterobacteriaceae, CRE, MDR Pseudomonas and Acinetobacter), Clostridioides difficile infection (NAP1/027 hypervirulent strain, two-step diagnostic algorithm, fidaxomicin first-line, bezlotoxumab, faecal microbiota transplant), infection control (five moments of hand hygiene, contact precautions, screening), antibiotic allergy delabeling (90 per cent of penicillin allergy labels are wrong), and procalcitonin-guided antibiotic cessation — structured for FRACP DWE and DCE preparation.

Open

high

Bloodstream Infections and Infective Endocarditis

Consultant-physician-depth guide to bacteraemia and infective endocarditis from the infectious-diseases side — blood culture technique, source control and catheter-related BSI, the modified Duke criteria applied, organism-by-context microbiology, empirical and definitive antimicrobial strategy with durations and the POET oral step-down, surgical triggers, and the S. aureus bacteraemia rule — structured for FRACP DWE and DCE preparation.

Open

high

Bone AND Joint Infections

Consultant-physician depth guide to Bone AND Joint Infections for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

high

Central Nervous System Infections

Consultant-physician-depth guide to meningitis, encephalitis and brain abscess — empirical therapy before imaging, CT-before-LP criteria, CSF interpretation, dexamethasone evidence, HSV aciclovir, and cryptococcal management — structured for FRACP DWE and DCE preparation.

Open

high

Healthcare-Associated Infections

Consultant-physician-depth guide to healthcare-associated infections (HAI) — the five major device-associated infection types (CRBSI/CLABSI, VAP, CAUTI, SSI, CDI), their clinical presentation, diagnosis, management and prevention, together with multi-drug resistant organisms (MRSA, VRE, ESBL, CRE), WHO Five Moments for Hand Hygiene, and evidence-based infection control bundles. Covers paired blood cultures and differential time to positivity for CRBSI, the ventilator bundle for VAP, the central line insertion checklist (Pronovost), surgical prophylaxis timing for SSI, the two-step C. difficile diagnostic algorithm with fidaxomicin first-line therapy, and the stewardship principles that prevent all HAIs. Structured for FRACP DWE MCQ, DCE long case and DCE short case, with MRCP and ABIM overlays.

Open

high

HIV and AIDS

Consultant-physician-depth guide to HIV infection and AIDS — viral lifecycle and CD4 depletion, natural history from acute seroconversion to advanced immunodeficiency, 4th-generation diagnostic strategy, antiretroviral therapy classes and first-line regimens (tenofovir/emtricitabine/dolutegravir or bictegravir), the START trial and Treat-All, opportunistic infections by CD4 threshold, prophylaxis, IRIS, AIDS-defining malignancies, pregnancy and U equals U, PrEP and PEP, drug interactions, and chronic comorbidities — structured for FRACP DWE and DCE preparation.

Open

high

Infections in the Immunocompromised Host

Consultant-physician-depth guide to the febrile immunocompromised patient — the central principle that the TYPE of immune defect predicts the organism, empiric therapy, and prophylaxis. Covers neutropenic fever (post-chemotherapy, AML induction) with the door-to-antibiotic protocol and piperacillin-tazobactam, the IDSA threshold of temperature above 38.3 single or above 38 sustained with neutrophils below 0.5, and G-CSF prophylaxis. Cellular immunodeficiency (HIV CD4-based; transplant 0 to 1 month nosocomial, 1 to 6 months opportunistic, above 6 months community) with PCP, Toxoplasma, Cryptococcus, HSV, VZV, CMV, MAC. Humoral immunodeficiency (myeloma, CLL, splenectomy) with encapsulated bacteria and vaccination. The solid organ transplant infection timeline, biologic therapy infections (anti-TNF and TB, rituximab and HBV, alemtuzumab and CMV), prophylaxis strategies (co-trimoxazole for PCP, valganciclovir for CMV D+/R-, fluconazole in high-risk neutropenia), and vaccination including avoidance of live vaccines — structured for FRACP DWE and DCE preparation.

Open

high

Invasive and Mucocutaneous Fungal Infections

Consultant-physician-depth guide to fungal infections in the immunocompromised and critically ill host — the central principle that the type of immune defect predicts the fungus, with systematic coverage of candidiasis (mucocutaneous and invasive, including candidaemia risk factors, empiric echinocandin for the unstable patient, and mandatory line removal), invasive pulmonary aspergillosis (halo sign, galactomannan, voriconazole first-line and isavuconazole alternative), cryptococcal meningitis (amphotericin B plus flucytosine induction, fluconazole consolidation, and the manage-raised-ICP principle with serial LPs), the endemic mycoses (Histoplasma, Blastomyces, Coccidioides, Paracoccidioides, Talaromyces), Pneumocystis jirovecii pneumonia (CD4 below 200, co-trimoxazole, adjunctive steroids), and rhinocerebral mucormycosis (ketoacidosis, black necrotic eschar, amphotericin plus debridement) — structured for FRACP DWE and DCE preparation.

Open

high

Sepsis and Septic Shock

Consultant-physician-depth guide to sepsis and septic shock — Sepsis-3 definitions (SOFA, qSOFA), pathophysiology of the dysregulated host response, Surviving Sepsis Campaign Hour-1 Bundle, vasopressor escalation, fluid responsiveness, source control, supportive care, and special situations (neutropenic sepsis, pregnancy, cirrhosis) — structured for FRACP DWE and DCE preparation.

Open

medium

Sexually Transmitted Infections

Consultant-physician depth guide to sexually transmitted infections for FRACP DWE/DCE preparation — CDC 2021 treatment guidelines, Neisseria gonorrhoeae and ceftriaxone monotherapy, Chlamydia trachomatis NAAT screening, syphilis staging and neurosyphilis, Mycoplasma genitalium and macrolide resistance, HSV suppressive therapy, HIV pre-exposure prophylaxis with tenofovir-emtricitabine, HPV vaccination, pelvic inflammatory disease, and syndromic management in resource-limited settings. Structured for FRACP DWE/DCE, MRCP and ABIM preparation.

Open

high

Tropical and Travel-Related Infections

Consultant-physician-depth guide to the febrile returning traveller — the incubation-period framework that narrows the differential, the rule-out-malaria-first principle, falciparum malaria (thick and thin films, RDT, IV artesunate for severe disease and artemether-lumefantrine for uncomplicated disease), dengue (breakbone fever, plasma leakage, warning signs, fluid-centred supportive care), enteric (typhoid) fever with the step-ladder pattern and ceftriaxone, rickettsial disease (eschar, doxycycline), schistosomiasis (Katayama fever, eosinophilia, praziquantel), leptospirosis (Weil disease), melioidosis in northern Australia (ceftazidime then prolonged oral eradication), the intestinal parasites giardia, amoeba and strongyloides (hyperinfection risk), the eosinophilia workup, and pre-travel advice — structured for FRACP DWE and DCE preparation.

Open

high

Tuberculosis

Consultant-physician-depth guide to tuberculosis — pathogenesis of Mycobacterium tuberculosis infection, primary versus reactivation disease, pulmonary and extrapulmonary TB, latent TB infection diagnosis and treatment, the RIPE regimen, drug-resistant TB (MDR/XDR and the BPaL regimen), and infection control — structured for FRACP DWE and DCE preparation.

Open

high

Tuberculosis

Consultant-physician-depth guide to tuberculosis as an infectious disease — latent versus active infection and who to screen, the diagnostic hierarchy from Xpert Ultra to culture, first-line RIPE therapy with drug-level toxicities, MDR/pre-XDR/XDR definitions and all-oral bedaquiline regimens, TB-HIV co-management and IRIS, and the public-health obligations of notification, contact tracing and BCG — structured for FRACP DWE and DCE preparation.

Open

high

Vaccine-Preventable Diseases and Adult Immunisation

Consultant-physician-depth guide to adult immunisation in the physician context — where comorbidity, immunosuppression, pregnancy, asplenia, and travel modify the standard schedule and turn each vaccine decision into a clinical-reasoning task. Covers the Australian NIP adult schedule (annual enhanced influenza above 65, pneumococcal PCV then PPSV23 or PCV20, recombinant zoster Shingrix above 50, dTpa every pregnancy 28 to 32 weeks, HPV catch-up to 25), the live-versus-inactivated principle that governs vaccination in immunocompromise, the pre-immunosuppression window (before rituximab, anti-TNF, transplant, chemotherapy), the asplenic vaccination-plus-prophylaxis bundle, travel medicine (yellow fever, Japanese encephalitis, typhoid, rabies), vaccine adverse events (anaphylaxis, Guillain-Barre after influenza, VAPP after oral polio, intussusception after rotavirus), and the communication strategies for vaccine hesitancy — structured for FRACP DWE and DCE preparation.

Open

high

Viral Hepatitis — Treatment and Surveillance (HBV, HCV, HDV)

Consultant-physician-depth guide to chronic viral hepatitis from the infectious-diseases side — HBV serology interpretation, the four phases and treatment thresholds, tenofovir versus entecavir, reactivation prophylaxis in immunosuppression, HCC surveillance, HCV test-and-cure with pangenotypic DAAs, HDV and HEV, vaccination and pregnancy — structured for FRACP DWE and DCE preparation.

Open

high

Zoonotic and Vector-Borne Infections

Consultant-physician-depth guide to the zoonotic and vector-borne infections relevant to ANZ and global practice — Q fever (Coxiella burnetii, phase I and II serology, doxycycline plus hydroxychloroquine for chronic endocarditis, Q-VAX vaccine), leptospirosis (biphasic illness, Weil disease, conjunctival suffusion, MAT serology, doxycycline and ceftriaxone), scrub typhus (eschar, Orientia tsutsugamushi, doxycycline, endemic in northern Australia), Queensland tick typhus (Rickettsia australis), brucellosis (undulant fever, doxycycline plus rifampicin for 6 weeks), Bartonella (cat-scratch disease, bacillary angiomatosis, culture-negative endocarditis), toxoplasmosis (cerebral toxoplasmosis in HIV, pyrimethamine-sulfadiazine-folinic acid), hantavirus (HFRS, pulmonary syndrome), Lyme disease (NOT endemic in Australia, imported only), and the ANZ-specific arboviruses — structured for FRACP DWE and DCE preparation.

Open

Domain

respiratory

16

high

Asthma and Severe Asthma

Consultant-physician-depth guide to asthma — T2 eosinophilic pathophysiology, spirometric and FeNO diagnosis, the GINA stepwise approach, severe asthma phenotyping and biologics (omalizumab, mepolizumab, benralizumab, dupilumab), and the acute severe asthma algorithm — structured for FRACP DWE and DCE preparation.

Open

medium

Bronchiectasis AND Suppurative Lung Disease

Consultant-physician depth guide to Bronchiectasis AND Suppurative Lung Disease for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

high

Chronic Obstructive Pulmonary Disease

Consultant-physician-depth guide to COPD — pathophysiology, spirometric diagnosis (GOLD), pharmacological and non-pharmacological management of stable disease, acute exacerbation management, and NIV in type 2 respiratory failure — structured for FRACP DWE and DCE preparation.

Open

high

Diffuse Alveolar Haemorrhage and Pulmonary-Renal Syndromes

Consultant-physician-depth guide to diffuse alveolar haemorrhage — the haemoptysis-absent trap, capillaritis versus bland versus diffuse alveolar damage mechanisms, serial BAL diagnosis, the ANCA/anti-GBM/SLE pulmonary-renal differential, and evidence-based severe DAH management from pulse methylprednisolone to plasma exchange — structured for FRACP DWE and DCE preparation.

Open

high

Interstitial Lung Disease

Consultant-physician-depth guide to the interstitial lung diseases — classification, HRCT pattern recognition, diagnostic approach, and evidence-based management of IPF and the progressive fibrosing ILDs — structured for FRACP DWE and DCE preparation.

Open

high

Lung Cancer

Consultant-physician-depth guide to lung cancer — the solitary pulmonary nodule workup, tissue and mediastinal staging, stage-mapped treatment intent, biomarker-first stage IV NSCLC therapy (EGFR, ALK, ROS1, KRAS G12C, PD-L1), SCLC as a fundamentally different disease, LDCT screening eligibility, oncological emergencies and early palliative care — structured for FRACP DWE and DCE preparation.

Open

medium

Lung Transplantation

Consultant-physician depth guide to lung transplantation — candidate selection and timing, Lung Allocation Score, perioperative primary graft dysfunction, immunosuppression (tacrolimus, mycophenolate, basiliximab), cytomegalovirus prophylaxis with valganciclovir, chronic lung allograft dysfunction (BOS/CLAD) and azithromycin, and ISHLT registry survival outcomes. Structured for FRACP DWE and DCE preparation.

Open

high

Obstructive Sleep Apnoea

Consultant-physician-depth guide to obstructive sleep apnoea (OSA) — pathophysiology of upper airway collapse, clinical features and Epworth Sleepiness Scale, cardiometabolic associations, diagnosis by polysomnography with AHI severity grading, STOP-BANG screening, and the full management ladder (lifestyle, CPAP, oral appliances, hypoglossal nerve stimulation, bariatric surgery) — structured for FRACP DWE and DCE preparation.

Open

medium

Occupational AND Environmental Lung Disease

Consultant-physician depth guide to Occupational AND Environmental Lung Disease for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

high

Pleural Disease

Consultant-physician-depth guide to pleural disease — pleural effusion (transudate vs exudate, Light's criteria, pleural fluid analysis, causes and investigation), parapneumonic effusion and empyema, malignant pleural effusion and mesothelioma, pneumothorax (primary spontaneous, secondary, tension) with BTS 2023 management algorithms — structured for FRACP DWE and DCE preparation.

Open

high

Pneumonia

Consultant-physician-depth guide to pneumonia — classification (CAP, HAP, VAP, aspiration, immunocompromised), pathogen patterns by setting, severity assessment (CURB-65, PSI, SMART-COP), investigations (CXR, urinary antigens, procalcitonin), empiric antibiotic therapy per IDSA/ATS 2019, corticosteroid adjunct in severe CAP, complications and prevention — structured for FRACP DWE and DCE preparation.

Open

high

Pulmonary Embolism

Consultant-physician-depth guide to pulmonary embolism — Virchow triad and risk factors, clinical probability (Wells, PERC, Revised Geneva), CTPA- and V/Q-based diagnosis, ESC risk stratification (PESI/sPESI, biomarkers, echo), anticoagulation with DOACs/LMWH, thrombolysis and embolectomy for massive PE, CTEPH, and special situations — structured for FRACP DWE and DCE preparation.

Open

medium

Pulmonary Vascular Disease AND COR Pulmonale

Consultant-physician depth guide to Pulmonary Vascular Disease AND COR Pulmonale for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

high

Respiratory Failure and Non-Invasive Ventilation

Consultant-physician-depth guide to acute respiratory failure — type 1 versus type 2 physiology, systematic ABG interpretation, controlled oxygen therapy, NIV in acidotic COPD exacerbation, CPAP in cardiogenic pulmonary oedema, HFNO, intubation triggers, domiciliary NIV and ceilings of care — structured for FRACP DWE and DCE preparation.

Open

high

Respiratory Investigation: PFTs, Bronchoscopy and Thoracoscopy

Consultant-physician-depth guide to respiratory investigation — spirometry and flow-volume loops, lung volumes and DLCO, bronchoprovocation testing, flexible bronchoscopy and EBUS-TBNA, navigational bronchoscopy, thoracentesis with Light's criteria, pleural biopsy routes and medical thoracoscopy — built around the question-first framework for FRACP DWE and DCE preparation.

Open

high

Solitary Pulmonary Nodule

Consultant-physician-depth guide to the solitary pulmonary nodule — the old-imaging-first principle, CT features that shift malignancy probability, subsolid nodule rules, Fleischner 2017 surveillance tables, Brock and Mayo risk models, the real limits of PET-CT, biopsy route selection (bronchoscopic, CT-guided, surgical) and the surveillance-plan conversation — structured for FRACP DWE and DCE preparation.

Open

Domain

oncological

8

medium

Breakthrough Cancer Pain AND Opioid Titration

Consultant-physician depth guide to Breakthrough Cancer Pain AND Opioid Titration for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

high

Breast Cancer (Physician Perspective)

Consultant-physician guide to breast cancer — the most common cancer in women worldwide and the second leading cause of cancer death. Organised around the receptor subtype framework (ER/PR, HER2, triple-negative) that drives every systemic therapy decision. Covers epidemiology and risk factors (BRCA1/2, PALB2, reproductive and lifestyle factors), BreastScreen Australia screening and high-risk MRI surveillance, pathology (DCIS, LCIS, invasive ductal and lobular), TNM staging, surgical principles (breast-conserving therapy, sentinel node biopsy), adjuvant and neoadjuvant systemic therapy (endocrine — tamoxifen and aromatase inhibitors with ovarian suppression; HER2-targeted — trastuzumab, pertuzumab, T-DM1; immunotherapy — pembrolizumab for triple-negative; PARP inhibition — olaparib for BRCA), metastatic management by site, treatment complications (cardiotoxicity, osteoporosis, endometrial cancer, lymphoedema), and hereditary risk reduction (BRCA — bilateral mastectomy and salpingo-oophorectomy).

Open

medium

Cancer Cachexia AND Nutritional Support

Consultant-physician depth guide to cancer cachexia and nutritional support — the Fearon 2011 definition and 2015 weight-loss classification, the IL-6 / GDF-15 / TNF inflammatory cascade, anorexia vs skeletal-muscle wasting vs adipose loss, ASCO 2020 and ESPEN 2017 guidelines, screening with PG-SGA and SGA, anthropometry plus CT-L3 skeletal-muscle index, oral nutritional supplements, enteral and parenteral nutrition, anamorelin (ROMANA), ghrelin agonists, medroxyprogesterone, omega-3 fatty acids, exercise prescription, and the ethics of clinically assisted hydration near end-of-life. Structured for FRACP DWE/DCE, MRCP and ABIM preparation.

Open

high

Immune Checkpoint Inhibitor Toxicity

Consultant-physician-depth guide to immune-related adverse events from checkpoint inhibitors — the mechanism of CTLA-4 and PD-1/PD-L1 blockade, the organ-specific irAE spectrum (skin, colitis, hepatitis, pneumonitis, endocrinopathy, myocarditis, nephritis, neurotoxicity), the CTCAE grading framework, the steroid-dose ladder, second-line infliximab, vedolizumab and mycophenolate, and the recognition of the fatal toxicities (myocarditis, pneumonitis). Structured for FRACP DWE and DCE preparation.

Open

high

Oncologic Emergencies

Consultant-physician-depth guide to the oncologic emergencies for FRACP DWE and DCE — febrile neutropenia (the one-hour door-to-antibiotic rule, MASCC risk stratification, empiric piperacillin-tazobactam), tumour lysis syndrome (Cairo-Bishop criteria, rasburicase for high risk), malignant spinal cord compression (dexamethasone 16 mg, MRI whole spine, the Patchell surgery decision), superior vena cava obstruction (stent for severe, treat the cancer), hypercalcaemia of malignancy (PTHrP-mediated, fluids then zoledronic acid then denosumab), hyperviscosity syndrome (urgent plasmapheresis), SIADH from small cell lung cancer, neoplastic cardiac tamponade, and leukostasis.

Open

high

Pain Management IN Cancer AND Chronic Disease

Consultant-physician depth guide to Pain Management IN Cancer AND Chronic Disease for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

high

Palliative Care and Symptom Management

Consultant-physician-depth guide to palliative care and symptom management for FRACP DWE and DCE — the WHO definition and the early-integration principle (Temel trial), the WHO three-step analgesic ladder for cancer pain (morphine, oxycodone, fentanyl; adjuvants gabapentin and dexamethasone; breakthrough at one-sixth; opioid rotation and methadone for refractory pain), cause-specific nausea and vomiting (metoclopramide for gastric stasis, haloperidol and olanzapine for chemical causes, cyclizine and hyoscine for bowel obstruction, dexamethasone for raised ICP), refractory breathlessness (oxygen if hypoxic, low-dose morphine, benzodiazepines, fan and positioning — Abernethy showed no benefit of oxygen over air in the non-hypoxaemic patient), terminal delirium and agitation (haloperidol first-line, midazolam for refractory), opioid-induced constipation (always co-prescribe a stimulant plus osmotic laxative), anorexia-cachexia (megestrol and corticosteroids with limited benefit), end-of-life care and anticipatory prescribing (the four injectable medicines), advance care planning, the SPIKES protocol for breaking bad news, and the ethics of capacity, substitute decision-making and voluntary assisted dying.

Open

medium

Prostate Cancer

Consultant-physician depth guide to prostate cancer for FRACP DWE/DCE preparation — PSA screening controversies and USPSTF guidance, multiparametric MRI and PI-RADS, targeted biopsy, Gleason grade grouping and risk stratification, active surveillance for low- and favourable-intermediate-risk disease, radical prostatectomy versus radiotherapy outcomes, androgen deprivation therapy complications and metabolic management, metastatic hormone-sensitive disease (CHAARTED, STAMPEDE, docetaxel and androgen-receptor pathway inhibitors), metastatic castration-resistant disease (abiraterone, enzalutamide, cabazitaxel, Radium-223, olaparib for BRCA-mutated disease, Lu-PSMA), bone health and palliation. Structured for FRACP DWE/DCE, MRCP and ABIM preparation.

Open

Domain

geriatric

12

high

Comprehensive Geriatric Assessment and Frailty

Consultant-physician-depth guide to comprehensive geriatric assessment (CGA) and frailty for FRACP DWE and DCE — the multidimensional interdisciplinary diagnostic process, the four domains (medical, functional, psychological, social), the Katz ADL index, the Lawton IADL scale, the Timed Up and Go test, the Fried frailty phenotype, the Rockwood frailty index, the Clinical Frailty Scale, the EWGSOP2 sarcopenia criteria, the MNA-SF nutrition screen, the 4AT delirium screen, the MoCA and GDS, the CGA delivery models, and the Cochrane meta-analysis evidence for reduced mortality and institutionalisation.

Open

high

Delirium

Consultant-physician-depth guide to delirium for FRACP DWE and DCE — DSM-5 definition, the Confusion Assessment Method, hyperactive versus hypoactive subtypes, neuroinflammatory and cholinergic pathophysiology, the DELIRIUM mnemonic for precipitants, HELP prevention, multicomponent non-pharmacological management, the narrow role of haloperidol, and the differentiation from dementia and depression.

Open

high

Dementia

Consultant-physician-depth guide to dementia for FRACP DWE and DCE — DSM-5 major neurocognitive disorder definition, the five major subtypes (Alzheimer, vascular, Lewy body, frontotemporal, mixed), mild cognitive impairment, cognitive assessment with MoCA and ACE-III, the reversible-cause workup, cholinesterase inhibitors and memantine, the BPSD escalation ladder, the antipsychotic contraindication in Lewy body dementia, driving and capacity, and the differentiation from delirium and depression.

Open

high

Elder Abuse and Safeguarding

Consultant-physician-depth guide to elder abuse and safeguarding for FRACP DWE and DCE — WHO definition, the six types of abuse (physical, psychological, financial, sexual, neglect, discriminatory), the 1-in-6 prevalence and severe underreporting, risk factors (dementia, carer stress, social isolation), the red flags of abuse, the EASI and Hwalek-Sengstock screening tools, the interview-alone principle, capacity assessment, mandatory reporting by jurisdiction, legal interventions (AVO, tribunal guardianship, financial management), support services, and the ethical balance of autonomy versus protection.

Open

high

End-of-Life Care and Advance Care Planning

Consultant-physician-depth guide to end-of-life care and advance care planning for FRACP DWE and DCE — the definition of end-of-life care as the last 12 months of life (not only the dying phase), advance care planning and the Surprise Question, advance directives as legally binding refusals, goals-of-care conversations and ceilings of treatment, recognising and managing the dying patient (last days of life), anticipatory prescribing and the Just In Case Box (morphine, midazolam, glycopyrronium, levomepromazine), the ethical equivalence of withholding and withdrawing treatment, voluntary assisted dying in Victoria and Western Australia, the SPIKES protocol for breaking bad news, and normal versus complicated bereavement.

Open

high

Falls and Syncope in Older Adults

Consultant-physician-depth guide to falls and syncope in older adults for FRACP DWE and DCE — epidemiology, the multifactorial risk-factor model, the focused assessment (gait, orthostatic BP, cognitive and cardiovascular), the evidence-graded multifactorial intervention bundle (Otago, tai chi, STOPP/START, home safety, pacemaker for cardioinhibitory carotid sinus hypersensitivity), and the ESC 2018 syncope classification (reflex, orthostatic, cardiac; and the TLOC mimics — seizure, hypoglycaemia, drop attack).

Open

medium

Nutrition AND Hydration IN Older Adults

Consultant-physician depth guide to Nutrition AND Hydration IN Older Adults for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

medium

Orthogeriatrics AND Perioperative Medicine IN Older Adults

Consultant-physician depth guide to Orthogeriatrics AND Perioperative Medicine IN Older Adults for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

high

Parkinson S Disease IN Older Adults

Consultant-physician depth guide to Parkinson's disease in older adults for FRACP DWE/DCE preparation — MDS clinical diagnostic criteria, levodopa pharmacology and motor complications (wearing-off, dyskinesia, on–off fluctuations), device-assisted therapies (apomorphine, levodopa–carbidopa intestinal gel, foslevodopa–foscarbidopa subcutaneous infusion, deep brain stimulation), non-motor symptoms (cognitive decline, psychosis, autonomic failure, falls, freezing of gait), pimavanserin for Parkinson's disease psychosis, palliative care at end of life, and adjustments for frailty, multimorbidity and polypharmacy. Structured for FRACP DWE/DCE, MRCP and ABIM preparation.

Open

high

Polypharmacy and Deprescribing

Consultant-physician-depth guide to polypharmacy and deprescribing for FRACP DWE and DCE — definitions of polypharmacy and hyperpolypharmacy, the pharmacokinetic changes of ageing, adverse drug reactions and the prescribing cascade, the Beers Criteria and STOPP/START version 3, medication reconciliation at transitions of care, high-risk medications in older adults, and the systematic deprescribing process with class-specific guidance for PPIs, statins, bisphosphonates, antihypertensives and benzodiazepines.

Open

medium

Pressure Injuries AND Wound Care

Consultant-physician depth guide to Pressure Injuries AND Wound Care for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

medium

Urinary Incontinence IN Older Adults

Consultant-physician depth guide to Urinary Incontinence IN Older Adults for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

Domain

dermatological

8

high

Cutaneous Manifestations of Systemic Disease

Consultant-physician-depth guide to the skin as a window to systemic disease — a system-by-system framework covering endocrine (acanthosis nigricans, necrolytic migratory erythema of glucagonoma, pretibial myxoedema, diabetic dermopathy), rheumatological (malar rash of SLE, Gottron papules and heliotrope rash of dermatomyositis, sclerodactyly, palpable purpura of vasculitis, erythema nodosum, pyoderma gangrenosum), gastrointestinal (dermatitis herpetiformis and coeliac disease, pyostomatitis vegetans), renal (calciphylaxis, nephrogenic systemic fibrosis), hepatic (spider naevi, palmar erythema), haematological (Sweet syndrome and AML, leukaemia cutis), paraneoplastic (dermatomyositis, malignant acanthosis nigricans, sign of Leser-Trelat, Trousseau syndrome), infectious (erythema chronicum migrans, secondary syphilis) and nutritional (scurvy, pellagra, acrodermatitis enteropathica) clues. Structured for FRACP DWE and DCE preparation.

Open

medium

Drug Eruptions AND Severe Cutaneous Adverse Reactions

Consultant-physician depth guide to drug eruptions and severe cutaneous adverse reactions — exanthematous, urticarial, pustular (AGEP), bullous (SJS/TEN), and the systemic hypersensitivity syndromes (DRESS/DIHS), SCORTEN prognostication, HLA-B*15:02 carbamazepine and HLA-B*58:01 allopurinol pharmacogenomics, supportive care guidelines, IVIG and ciclosporin controversy, long-term sequelae including chronic ocular disease, and drug provocation testing principles. Structured for FRACP DWE/DCE, MRCP and ABIM preparation.

Open

medium

Erythema Nodosum AND Panniculitis

Consultant-physician depth guide to erythema nodosum and the panniculitides for FRACP DWE/DCE — septal vs lobular classification, Löfgren syndrome, erythema induratum and tuberculosis, alpha-1 antitrypsin deficiency panniculitis, pancreatic panniculitis, Weber-Christian disease, lipodermatosclerosis, biopsy interpretation, drug and infection triggers, corticosteroid and dapsone dosing, and the multisystem workup the examiner expects. Structured for FRACP DWE/DCE, MRCP and ABIM preparation.

Open

medium

Genodermatoses with Systemic Significance

Consultant-physician depth guide to genodermatoses with systemic significance for FRACP DWE/DCE — neurofibromatosis type 1 (NF1) revised diagnostic criteria and MEK inhibitor therapy for plexiform neurofibromas, tuberous sclerosis complex (TSC) with mTOR inhibitors, Sturge-Weber syndrome and GNAQ mosaicism, hereditary haemorrhagic telangiectasia (Curaçao criteria), X-linked ichthyosis with STS deficiency, Darier disease (ATP2A2), pseudoxanthoma elasticum (ABCC6), and the multisystem surveillance the physician must orchestrate. Structured for FRACP DWE/DCE, MRCP and ABIM preparation.

Open

medium

Malignant Skin Lesions

Consultant-physician depth guide to Malignant Skin Lesions for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

medium

Pyoderma Gangrenosum AND Neutrophilic Dermatoses

Consultant-physician depth guide to Pyoderma Gangrenosum AND Neutrophilic Dermatoses for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

medium

Skin Signs OF Internal Malignancy

Consultant-physician depth guide to Skin Signs OF Internal Malignancy for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

medium

Vasculitic Skin Lesions

Consultant-physician depth guide to Vasculitic Skin Lesions for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

Domain

neurological

16

high

Epilepsy

Consultant-physician-depth guide to seizure classification (ILAE 2017), epilepsy syndromes, pathophysiology of neuronal hyperexcitability, EEG and MRI investigation, syndrome-based antiepileptic drug selection, status epilepticus management, and women-with-epilepsy care for FRACP DWE and DCE preparation.

Open

high

Guillain-Barre Syndrome

Consultant-physician-depth guide to Guillain-Barre syndrome — immune-mediated demyelination of peripheral nerves via molecular mimicry and anti-ganglioside antibodies, ascending weakness with areflexia, CSF albuminocytologic dissociation and nerve conduction studies, IVIG versus plasma exchange, respiratory and autonomic monitoring, and the CIDP boundary — for FRACP DWE and DCE preparation.

Open

high

Meningitis and Encephalitis

Consultant-physician-depth guide to central nervous system infections — bacterial meningitis empiric therapy and corticosteroid timing, HSV encephalitis and aciclovir, tuberculous and cryptococcal meningitis, and autoimmune encephalitis — for FRACP DWE and DCE preparation.

Open

high

Motor Neuron Disease

Consultant-physician-depth guide to motor neuron disease (amyotrophic lateral sclerosis): degeneration of both upper and lower motor neurons, glutamate excitotoxicity and C9orf72/SOD1 genetics, the combined UMN-and-LMN-in-the-same-region diagnostic hallmark, El Escorial / Awaji / Gold Coast criteria, exclusion of mimics (cervical myelopathy, multifocal motor neuropathy, Kennedy disease), riluzole and edaravone, and multidisciplinary care with non-invasive ventilation, PEG and advance care planning for FRACP DWE and DCE preparation.

Open

high

Movement Disorders

Consultant-physician-depth guide to parkinsonism and the hyperkinetic movement disorders for FRACP DWE and DCE — Parkinson's disease pathology and the levodopa escalation ladder, atypical parkinsonism (MSA, PSP, CBD, DLB), drug-induced parkinsonism, essential tremor, dystonia, Huntington disease, Wilson disease, restless legs syndrome and tic disorders.

Open

high

Multiple Sclerosis

Consultant-physician-depth guide to multiple sclerosis — the demyelinating autoimmune disease of the CNS. Covers the clinical course (RRMS 85 per cent at onset, SPMS, PPMS 15 per cent), pathophysiology (T-cell mediated attack on CNS myelin; HLA-DRB1*15:01; EBV, vitamin D, latitude, smoking), the clinical syndromes (optic neuritis, transverse myelitis, brainstem, cerebellar; Lhermitte sign, Uhthoff phenomenon), the McDonald 2017 diagnostic criteria (dissemination in space and time on MRI, CSF oligoclonal bands, VEP delayed P100), acute relapse management (methylprednisolone, plasma exchange), the full DMT landscape (interferon, glatiramer, fingolimod, dimethyl fumarate, teriflunomide, cladribine, siponimod, natalizumab with PML risk, ocrelizumab for PPMS and RRMS, alemtuzumab, HSCT), symptom management (spasticity, fatigue, bladder, depression, pain), and pregnancy planning (washout, relapse rate in pregnancy, postpartum rebound, breastfeeding). Structured for FRACP DWE and DCE preparation.

Open

high

Myasthenia Gravis

Consultant-physician-depth guide to myasthenia gravis: autoimmune neuromuscular junction pathology (anti-AChR, anti-MuSK), fatigable weakness across ocular, bulbar, limb and respiratory muscles, bedside and serological diagnosis, pyridostigmine and immunosuppression, thymectomy (MGTX), and myasthenic crisis management for FRACP DWE and DCE preparation.

Open

medium

Neurocutaneous Syndromes

Consultant-physician depth guide to Neurocutaneous Syndromes for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

high

Neurological Investigation LP EMG NCS EEG Neuroimaging

Consultant-physician depth guide to neurological investigation — lumbar puncture and cerebrospinal fluid analysis (cells, glucose, protein, opening pressure, oligoclonal bands), nerve conduction studies and needle electromyography (demyelinating versus axonal, Guillain-Barré electrodiagnosis), single-fibre EMG for myasthenia gravis, visual evoked potentials in the 2024 McDonald criteria, EEG in epilepsy and non-convulsive status epilepticus, and structural neuroimaging (CT versus MRI, diffusion-weighted imaging and FLAIR mismatch in acute stroke). Structured for FRACP DWE and DCE preparation.

Open

high

Peripheral Neuropathy

Consultant-physician-depth systematic approach to peripheral neuropathy. Covers the four classification axes — fibre type (motor, sensory, autonomic, mixed), distribution (distal symmetric, mononeuropathy, mononeuritis multiplex, polyradiculoneuropathy), time course (acute, subacute, chronic), and pathology (axonal versus demyelinating — the key NCS discriminator). The full differential by cause: diabetes (the most common, with DSPN and cranial and lumbosacral variants), alcohol and thiamine, B12 and folate, B1 beriberi, B6 toxicity, vitamin E, drug-induced (vincristine, cisplatin, isoniazid, amiodarone, metronidazole, phenytoin, statins), toxins (lead, arsenic, mercury, organophosphates), hereditary (CMT, HNPP), autoimmune (GBS, CIDP, vasculitis), paraproteinaemic (MGUS, myeloma, amyloid, POEMS), uraemic, and critical illness (CIP/CIM). Investigation pathway (NCS/EMG, bloods, CSF, genetics, biopsy) and management (treat the cause, neuropathic pain, foot care, falls and burns prevention). Structured for FRACP DWE and DCE preparation.

Open

high

Raised Intracranial Pressure AND Brain Tumours

Consultant-physician depth guide to raised intracranial pressure and brain tumours for FRACP DWE/DCE preparation — cerebral herniation syndromes, vasogenic versus cytotoxic oedema, glioblastoma Stupp regimen, meningioma WHO 2021 grading, brain metastases and stereotactic radiosurgery, dexamethasone and hyperosmolar therapy, CSF shunts and hydrocephalus, palliative end-of-life care. Structured for FRACP DWE/DCE, MRCP and ABIM preparation.

Open

high

Spinal Cord Disease

Consultant-physician-depth guide to spinal cord anatomy, the cord syndromes (complete transection, anterior cord, Brown-Sequard, central cord, posterior column), malignant spinal cord compression with the Patchell criteria, cauda equina syndrome, syringomyelia, transverse myelitis and B12 deficiency subacute combined degeneration — for FRACP DWE and DCE preparation.

Open

high

Stroke

Consultant-physician-depth guide to acute stroke — classification, pathophysiology of the ischaemic penumbra, vascular territory localisation, IV thrombolysis and mechanical thrombectomy protocols, and integrated secondary prevention for FRACP DWE and DCE preparation.

Open

high

Subarachnoid Haemorrhage AND Intracranial Haemorrhage

Consultant-physician depth guide to Subarachnoid Haemorrhage AND Intracranial Haemorrhage for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open

high

Transient Ischaemic Attack and Carotid Disease

Consultant-physician guide to TIA and symptomatic carotid disease — tissue-based definition, urgent risk stratification, dual antiplatelet therapy after high-risk TIA or minor stroke, carotid imaging and revascularisation thresholds, and secondary prevention — structured for FRACP DWE and DCE.

Open

medium

Vestibular Disorders

Consultant-physician depth guide to Vestibular Disorders for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

Open